Cover
Cover - shares | 6 Months Ended | |
Jun. 30, 2024 | Aug. 07, 2024 | |
Affiliate, Collateralized Security [Line Items] | ||
Document Type | 10-Q | |
Amendment Flag | false | |
Document Quarterly Report | true | |
Document Transition Report | false | |
Document Period End Date | Jun. 30, 2024 | |
Document Fiscal Period Focus | Q2 | |
Document Fiscal Year Focus | 2024 | |
Current Fiscal Year End Date | --12-31 | |
Entity File Number | 001-38785 | |
Entity Registrant Name | STRYVE FOODS, INC. | |
Entity Central Index Key | 0001691936 | |
Entity Tax Identification Number | 87-1760117 | |
Entity Incorporation, State or Country Code | DE | |
Entity Address, Address Line One | Post Office Box 864 | |
Entity Address, City or Town | Frisco | |
Entity Address, State or Province | TX | |
Entity Address, Postal Zip Code | 75034 | |
City Area Code | 972 | |
Local Phone Number | 987-5130 | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Entity Small Business | true | |
Entity Emerging Growth Company | true | |
Entity Ex Transition Period | false | |
Entity Shell Company | false | |
Class A Common Stock [Member] | ||
Affiliate, Collateralized Security [Line Items] | ||
Title of 12(b) Security | Class A common stock | |
Trading Symbol | SNAX | |
Security Exchange Name | NASDAQ | |
Entity Common Stock, Shares Outstanding | 2,964,692 | |
Warrants, each exercisable for 1/15th of one share of Class A common stock at an exercise price of $172.50 per whole share [Member] | ||
Affiliate, Collateralized Security [Line Items] | ||
Title of 12(b) Security | Warrants, each exercisable for 1/15th of one share of Class A common stock at an exercise price of $172.50 per whole share | |
Trading Symbol | SNAXW | |
Security Exchange Name | NASDAQ | |
Class V Common Stock [Member] | ||
Affiliate, Collateralized Security [Line Items] | ||
Entity Common Stock, Shares Outstanding | 380,260 |
Condensed Consolidated Balance
Condensed Consolidated Balance Sheets - USD ($) | Jun. 30, 2024 | Dec. 31, 2023 |
CURRENT ASSETS | ||
Cash and cash equivalents | $ 447,342 | $ 369,114 |
Accounts receivable, net | 2,953,106 | 2,091,926 |
Inventory | 4,801,372 | 5,199,979 |
Prepaid expenses and other current assets | 396,035 | 720,682 |
Total current assets | 8,597,855 | 8,381,701 |
Property and equipment, net | 6,447,865 | 7,150,775 |
Right of use assets, net | 4,401,214 | 4,609,666 |
Goodwill | 8,450,000 | 8,450,000 |
Intangible assets, net | 3,998,523 | 4,119,690 |
TOTAL ASSETS | 31,895,457 | 32,711,832 |
CURRENT LIABILITIES | ||
Accounts payable | 5,670,082 | 4,459,787 |
Accrued expenses | 2,683,185 | 2,687,508 |
Current portion of lease liability | 326,374 | 362,165 |
Line of credit, net of debt issuance costs | 4,168,800 | 3,568,295 |
Current portion of long-term debt and other short-term borrowings | 422,615 | 605,530 |
Total current liabilities | 20,291,789 | 15,772,285 |
Long-term debt, net of current portion, net of debt issuance costs | 3,331,078 | 3,476,089 |
Lease liability, net of current portion | 4,231,726 | 4,371,963 |
Financing obligation - related party operating lease | 7,500,000 | 7,500,000 |
Deferred tax liability, net | 35 | 35 |
TOTAL LIABILITIES | 35,354,628 | 31,120,372 |
COMMITMENTS AND CONTINGENCIES (Note 12) | ||
STOCKHOLDERS' (DEFICIT) EQUITY | ||
Preferred stock - $0.0001 par value, 10,000,000 shares authorized, 0 shares issued and outstanding | ||
Additional paid-in-capital | 139,723,357 | 137,883,798 |
Accumulated deficit | (143,182,861) | (136,292,600) |
TOTAL STOCKHOLDERS' (DEFICIT) EQUITY | (3,459,171) | 1,591,460 |
TOTAL LIABILITIES AND STOCKHOLDERS' (DEFICIT) EQUITY | 31,895,457 | 32,711,832 |
Related Party [Member] | ||
CURRENT LIABILITIES | ||
Promissory notes payable, net of debt discount and debt issuance costs | 2,863,751 | 1,175,000 |
Nonrelated Party [Member] | ||
CURRENT LIABILITIES | ||
Promissory notes payable, net of debt discount and debt issuance costs | 4,156,982 | 2,914,000 |
Class A Common Stock [Member] | ||
STOCKHOLDERS' (DEFICIT) EQUITY | ||
Common stock | 295 | 224 |
Class V Common Stock [Member] | ||
STOCKHOLDERS' (DEFICIT) EQUITY | ||
Common stock | $ 38 | $ 38 |
Condensed Consolidated Balanc_2
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares | Jun. 30, 2024 | Dec. 31, 2023 |
Preferred Stock, par value | $ 0.0001 | $ 0.0001 |
Preferred Stock, shares authorized | 10,000,000 | 10,000,000 |
Preferred Stock, shares issued | 0 | 0 |
Preferred Stock, shares outstanding | 0 | 0 |
Class A Common Stock [Member] | ||
Common stock, par value | $ 0.0001 | $ 0.0001 |
Common stock, shares authorized | 400,000,000 | 400,000,000 |
Common Stock, shares issued | 2,964,653 | 2,249,189 |
Common Stock, shares outstanding | 2,964,653 | 2,249,189 |
Treasury shares | 53,333 | 53,333 |
Class V Common Stock [Member] | ||
Common stock, par value | $ 0.0001 | $ 0.0001 |
Common stock, shares authorized | 15,000,000 | 15,000,000 |
Common Stock, shares issued | 380,260 | 382,892 |
Common Stock, shares outstanding | 380,260 | 382,892 |
Condensed Consolidated Statemen
Condensed Consolidated Statements of Operations (Unaudited) - USD ($) | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | |
Income Statement [Abstract] | ||||
SALES, net | $ 6,177,902 | $ 5,996,541 | $ 10,776,061 | $ 10,642,794 |
COST OF GOODS SOLD (exclusive of depreciation shown separately below) | 4,484,309 | 4,945,856 | 8,066,084 | 8,628,859 |
GROSS PROFIT | 1,693,593 | 1,050,685 | 2,709,977 | 2,013,935 |
OPERATING EXPENSES | ||||
Selling expenses | 1,577,148 | 1,778,274 | 3,173,685 | 3,747,283 |
Operations expense | 411,661 | 625,289 | 764,409 | 1,138,878 |
Salaries and wages | 1,529,951 | 1,469,307 | 3,136,964 | 3,632,459 |
Depreciation and amortization expense | 407,786 | 552,224 | 870,317 | 1,103,880 |
Gain on disposal of fixed assets | 0 | 1,295 | 0 | 1,295 |
Total operating expenses | 3,926,546 | 4,426,389 | 7,945,375 | 9,623,795 |
OPERATING LOSS | (2,232,953) | (3,375,704) | (5,235,398) | (7,609,860) |
OTHER (EXPENSE) INCOME | ||||
Interest expense | (727,894) | (963,784) | (1,310,460) | (1,362,729) |
Loss on extinguishment of debt | 0 | 0 | (334,511) | 0 |
Change in fair value of Private Warrants | 0 | 10,400 | 0 | 18,650 |
Other income (expense) | 0 | 7,417 | 6 | (6,956) |
Total other (expense) income | (727,894) | (945,967) | (1,644,965) | (1,351,035) |
NET LOSS BEFORE INCOME TAXES | (2,960,847) | (4,321,671) | (6,880,363) | (8,960,895) |
Income tax expense (benefit) | 900 | (12,854) | 9,898 | (9,523) |
NET LOSS | $ (2,961,747) | $ (4,308,817) | $ (6,890,261) | $ (8,951,372) |
Loss per common share: | ||||
Basic | $ (0.91) | $ (2.05) | $ (2.29) | $ (4.27) |
Diluted | $ (0.91) | $ (2.05) | $ (2.29) | $ (4.27) |
Weighted average shares outstanding: | ||||
Basic | 3,254,028 | 2,105,620 | 3,014,671 | 2,095,621 |
Diluted | 3,254,028 | 2,105,620 | 3,014,671 | 2,095,621 |
Condensed Consolidated Statem_2
Condensed Consolidated Statements of Changes in Stockholders' (Deficit) Equity (Unaudited) - USD ($) | Total | At-The-Market Offerings [Member] | Common Stock [Member] Class A Common Stock [Member] | Common Stock [Member] Class A Common Stock [Member] At-The-Market Offerings [Member] | Common Stock [Member] Class V Common Stock [Member] | Additional Paid-in Capital [Member] | Additional Paid-in Capital [Member] At-The-Market Offerings [Member] | Accumulated Deficit [Member] |
Balance at Dec. 31, 2022 | $ 16,436,185 | $ 172 | $ 42 | $ 133,687,587 | $ (117,251,616) | |||
Balance, shares at Dec. 31, 2022 | 1,714,973 | 419,941 | ||||||
Exchange of Class B units and Class V shares for Class A shares | $ 1 | $ (1) | ||||||
Exchange of Class B units and Class V shares for Class A shares, shares | 10,241 | (10,241) | ||||||
Net loss | (4,642,556) | (4,642,556) | ||||||
Balance at Mar. 31, 2023 | 11,793,629 | $ 173 | $ 41 | 133,687,587 | (121,894,172) | |||
Balance, shares at Mar. 31, 2023 | 1,725,214 | 409,700 | ||||||
Balance at Dec. 31, 2022 | 16,436,185 | $ 172 | $ 42 | 133,687,587 | (117,251,616) | |||
Balance, shares at Dec. 31, 2022 | 1,714,973 | 419,941 | ||||||
Net loss | (8,951,372) | |||||||
Balance at Jun. 30, 2023 | 9,360,719 | $ 176 | $ 41 | 135,563,491 | (126,202,989) | |||
Balance, shares at Jun. 30, 2023 | 1,757,588 | 405,313 | ||||||
Balance at Mar. 31, 2023 | 11,793,629 | $ 173 | $ 41 | 133,687,587 | (121,894,172) | |||
Balance, shares at Mar. 31, 2023 | 1,725,214 | 409,700 | ||||||
Issuance of Restricted Stock Awards | 477,158 | $ 3 | 477,155 | |||||
Issuance of Restricted Stock Awards, shares | 26,814 | |||||||
Issuance of Restricted Stock Units | 62,752 | 62,752 | ||||||
Issuance of Restricted Stock Units, Shares | 1,173 | |||||||
Exchange of Class B units and Class V shares for Class A shares, shares | 4,387 | (4,387) | ||||||
Issuance of Warrants in connection with Debt Instrument | 1,335,997 | 1,335,997 | ||||||
Net loss | (4,308,817) | (4,308,817) | ||||||
Balance at Jun. 30, 2023 | 9,360,719 | $ 176 | $ 41 | 135,563,491 | (126,202,989) | |||
Balance, shares at Jun. 30, 2023 | 1,757,588 | 405,313 | ||||||
Balance at Dec. 31, 2023 | 1,591,460 | $ 224 | $ 38 | 137,883,798 | (136,292,600) | |||
Balance, shares at Dec. 31, 2023 | 2,249,189 | 382,892 | ||||||
Cancellation of Restricted Stock Awards, shares | (350) | |||||||
Issuance of Restricted Stock Units, Shares | 691 | |||||||
Stock-based compensation expense | 270,376 | 270,376 | ||||||
Issuance of Class A Shares | $ 711,031 | $ 56 | $ 710,975 | |||||
Issuance of Class A Shares, shares | 558,873 | |||||||
Change in Fair Value of Warrants on Extinguishment of Debt | 334,511 | 334,511 | ||||||
Common Stock Issued for Accrued Expenses | 147,287 | $ 5 | 147,282 | |||||
Common Stock Issued for Accrued Expenses, shares | 53,559 | |||||||
Common Stock Issued for Accrued Expenses - Related Party | 100,000 | $ 4 | 99,996 | |||||
Common Stock Issued for Accrued Expenses - Related Party, shares | 36,232 | |||||||
Net loss | (3,928,514) | (3,928,514) | ||||||
Balance at Mar. 31, 2024 | (773,849) | $ 289 | $ 38 | 139,446,938 | (140,221,114) | |||
Balance, shares at Mar. 31, 2024 | 2,898,194 | 382,892 | ||||||
Balance at Dec. 31, 2023 | 1,591,460 | $ 224 | $ 38 | 137,883,798 | (136,292,600) | |||
Balance, shares at Dec. 31, 2023 | 2,249,189 | 382,892 | ||||||
Common Stock Issued for Accrued Expenses | 147,287 | |||||||
Common Stock Issued for Accrued Expenses - Related Party | 100,000 | |||||||
Net loss | (6,890,261) | |||||||
Balance at Jun. 30, 2024 | (3,459,171) | $ 295 | $ 38 | 139,723,357 | (143,182,861) | |||
Balance, shares at Jun. 30, 2024 | 2,964,653 | 380,260 | ||||||
Balance at Mar. 31, 2024 | (773,849) | $ 289 | $ 38 | 139,446,938 | (140,221,114) | |||
Balance, shares at Mar. 31, 2024 | 2,898,194 | 382,892 | ||||||
Issuance of Restricted Stock Awards | $ 5 | (5) | ||||||
Issuance of Restricted Stock Awards, shares | 50,832 | |||||||
Issuance of Restricted Stock Units | $ 1 | (1) | ||||||
Issuance of Restricted Stock Units, Shares | 12,995 | |||||||
Stock-based compensation expense | 276,425 | 276,425 | ||||||
Exchange of Class B units and Class V shares for Class A shares, shares | 2,632 | (2,632) | ||||||
Net loss | (2,961,747) | (2,961,747) | ||||||
Balance at Jun. 30, 2024 | $ (3,459,171) | $ 295 | $ 38 | $ 139,723,357 | $ (143,182,861) | |||
Balance, shares at Jun. 30, 2024 | 2,964,653 | 380,260 |
Condensed Consolidated Statem_3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) | 6 Months Ended | |
Jun. 30, 2024 | Jun. 30, 2023 | |
CASH FLOWS FROM OPERATING ACTIVITIES | ||
Net loss | $ (6,890,261) | $ (8,951,373) |
Adjustments to reconcile net loss to net cash used in operating activities: | ||
Depreciation expense | 749,150 | 982,713 |
Amortization of intangible assets | 121,167 | 121,167 |
Amortization of debt issuance costs | 109,586 | 124,519 |
Amortization of debt discount | 386,615 | |
Amortization of debt premium | 6,733 | |
Amortization of right-of-use asset | 208,453 | 196,977 |
Loss on extinguishment of debt | 334,511 | 0 |
Gain on disposal of fixed assets | 1,295 | |
Reserve for credit losses | 221,920 | 80,206 |
Stock based compensation expense | 546,802 | 617,965 |
Change in fair value of Private Warrants | 0 | (18,650) |
Changes in operating assets and liabilities: | ||
Accounts receivable | (1,083,101) | (564,156) |
Inventory | 398,607 | (92,653) |
Prepaid expenses and other current assets | 324,647 | 478,804 |
Accounts payable | 1,178,242 | 1,502,358 |
Accrued liabilities | 242,964 | 87,646 |
Operating lease obligations | (176,028) | (166,114) |
Net cash used in operating activities | (3,706,608) | (5,212,681) |
CASH FLOWS FROM INVESTING ACTIVITIES | ||
Cash paid for purchase of equipment | (14,187) | (64,148) |
Net cash used in investing activities | (14,187) | (64,148) |
CASH FLOWS FROM FINANCING ACTIVITIES | ||
Proceeds from the issuance of common stock, net | 711,031 | |
Repayments on long-term debt | (68,355) | (76,193) |
Borrowings on related party debt | 1,685,000 | 1,175,000 |
Borrowings on short-term debt | 10,163,990 | 12,967,206 |
Repayments on short-term debt | (8,692,643) | (8,877,244) |
Debt issuance costs | (176,287) | |
Deferred offering costs | (38,634) | |
Net cash provided by financing activities | 3,799,023 | 4,973,848 |
Net change in cash and cash equivalents | 78,228 | (302,981) |
Cash and cash equivalents at beginning of period | 369,114 | 623,163 |
Cash and cash equivalents at end of period | 447,342 | 320,182 |
SUPPLEMENTAL INFORMATION: | ||
Cash paid for interest | 879,357 | 755,024 |
NON-CASH INVESTING AND FINANCING ACTIVITY: | ||
Non-cash commercial premium finance borrowing | $ 291,339 | |
Common stock issued for accrued expenses | 147,287 | |
Common stock issued for accrued expenses - related party | 100,000 | |
Accrued fixed assets | $ 32,052 |
Pay vs Performance Disclosure
Pay vs Performance Disclosure - USD ($) | 3 Months Ended | 6 Months Ended | ||||
Jun. 30, 2024 | Mar. 31, 2024 | Jun. 30, 2023 | Mar. 31, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | |
Pay vs Performance Disclosure | ||||||
Net Income (Loss) | $ (2,961,747) | $ (3,928,514) | $ (4,308,817) | $ (4,642,556) | $ (6,890,261) | $ (8,951,372) |
Insider Trading Arrangements
Insider Trading Arrangements | 3 Months Ended |
Jun. 30, 2024 | |
Trading Arrangements, by Individual | |
Rule 10b5-1 Arrangement Adopted | false |
Non-Rule 10b5-1 Arrangement Adopted | false |
Rule 10b5-1 Arrangement Terminated | false |
Non-Rule 10b5-1 Arrangement Terminated | false |
Rule 10b5-1 Arrangement Modified | false |
Non Rule 10b5-1 Arrangement Modified | false |
Organization and Description of
Organization and Description of Business | 6 Months Ended |
Jun. 30, 2024 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Organization and Description of Business | Note 1 - Organization and Description of Business Stryve Foods, Inc. (“Stryve” or the “Company”) is an emerging healthy snacking company which manufactures, markets and sells highly differentiated healthy snacking products. The Company offers convenient snacks that are lower in sugar and carbohydrates and higher in protein than other snacks. The Company is headquartered in Plano, TX. The Company has manufacturing operations in Madill, Oklahoma and fulfillment operations in Frisco, Texas. Reverse Stock Split On July 13, 2023, the Company filed with the Secretary of State of the State of Delaware a First Certificate of Amendment to its First Amended and Restated Certificate of Incorporation (the “Certificate”) to effect a 1-for-15 reverse stock split (the “Reverse Stock Split”) of the Company’s issued and outstanding shares of common stock, par value $ 0.0001 per share, effective as of 12:01 p.m. Eastern Time on July 14, 2023. All share and per share amounts were retroactively adjusted in the Company's financial statements for all periods presented to give effect to this reverse stock split, including reclassifying an amount equal to the reduction in par value of the Company’s common stock to additional paid-in capital. |
Liquidity and Going Concern
Liquidity and Going Concern | 6 Months Ended |
Jun. 30, 2024 | |
Liquidity And Going Concern [Abstract] | |
Liquidity and Going Concern | Note 2 - Liquidity and Going Concern The accompanying condensed consolidated financial statements are prepared in accordance with generally accepted accounting principles applicable to a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. In accordance with ASU No. 2014-15, Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going concern (Subtopic 205-40) , the Company has evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about its ability to continue as a going concern within one year after the date that the condensed consolidated financial statements are issued. The Company has historically funded its operations with cash flow from operations, equity capital raises, and note payable agreements from shareholders and private investors, in addition to institutional loans. The Company's principal uses of cash have been debt service, capital expenditures, working capital, and funding operations. The Company incurred net losses of approximately $ 6.9 million during the six months ended June 30, 2024. Cash used in operating activities was approximately $ 3.7 million for the six months ended June 30, 2024. As of June 30, 2024, the Company has a working capital deficit of $ 11.7 million which compares to $ 7.4 million as of December 31, 2023. Late in the third quarter of 2022, the Company secured a term loan in the amount of $ 4.0 million. Additionally, the Company secured an asset based line of credit with a $ 8.0 million credit limit subject to accounts receivable and inventory balances. The term loan and asset based line of credit were secured in order to augment the Company's liquidity, as needed, through the execution of management's transformation plan. The Company's initial draw on the term loan was $ 4.0 million taken in 2022 and as of June 30, 2024, $ 4.2 million (net of repayments) has been drawn on the asset based line of credit. The unused committed capacity under the asset based line of credit is $ 3.8 million as of June 30, 2024 , however, actual borrowing availability at any time is subject to advance rates on accounts receivable and inventory balances. No amount remained available to draw under the term loan as of June 30, 2024. See Note 5 for a description of the asset based line of credit and Note 6 for a description of the term loan. During the second quarter of 2024, we issued an aggregate of $ 3.0 million in principal amount of unsecured promissory notes (the “Convertible Notes”) to select accredited investors to fund operations. The aggregate principal amount of the Convertible Notes is inclusive of $ 1.7 million from related parties. See Note 6 for further discussion. We are currently evaluating several different strategies to enhance our liquidity position. These strategies may include, but are not limited to, pursuing additional actions under our business transformation plan, seeking to refinance or extend the term of outstanding debt and seeking additional financing from both the public and private markets through the issuance of equity or debt securities. The outcome of these matters cannot be predicted with any certainty at this time. There can be no assurance that we will be able to raise the capital we need to continue our operations on satisfactory terms or at all. We need additional funding to execute our business plan and continue operations. If capital is not available to us when, and in the amounts needed, we could be required to liquidate our inventory and assets, cease or curtail operations, which could materially harm our business, financial condition and results of operations, or seek protection under applicable bankruptcy laws or similar state proceedings. We have prepared cash flow forecasts which indicate that based on our expected operating losses and cash consumption in order to fund working capital growth, we believe that absent an infusion of sufficient capital there is substantial doubt about our ability to continue as a going concern for twelve months after the date the condensed consolidated financial statements for the quarter ended June 30, 2024 are issued. The Company's plan includes the items noted above as well as securing external financing which may include raising debt or equity capital. These plans are not entirely within the Company's control including our ability to raise sufficient capital on favorable terms, if at all. |
Significant Accounting Policies
Significant Accounting Policies | 6 Months Ended |
Jun. 30, 2024 | |
Accounting Policies [Abstract] | |
Significant Accounting Policies | Note 3 - Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States ("GAAP") for interim financial information and in accordance with the rules and regulations of the Securities and Exchange Commission ("SEC"). Accordingly, these interim financial statements do not include all information and footnotes required under GAAP for complete financial statements. In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments, consisting of only normal recurring adjustments, necessary for a fair statement of results of operations, balance sheet, cash flows, and shareholders' equity for the periods presented. The unaudited condensed consolidated results of operations for the interim periods presented are not necessarily indicative of results for the full year. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in the Company’s Annual Report filed on Form 10-K for the year ended December 31, 2023 . The Company’s condensed consolidated financial statements include the accounts of the Company and its subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. Certain information and footnote disclosures normally included in the annual consolidated financial statements prepared in accordance with GAAP have been condensed or omitted. Use of Estimates The preparation of the condensed consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Accounting estimates and assumptions discussed herein are those that management considers to be the most critical to an understanding of the condensed consolidated financial statements because they inherently involve significant judgments and uncertainties. Estimates are used for, but not limited to revenue recognition, allowance for credit losses and customer allowances, inventory valuation, impairments of goodwill and long-lived assets, incremental borrowing rate for leases, and valuation allowances for deferred tax assets. All of these estimates reflect management’s judgment about current economic and market conditions and their effects based on information available as of the date of these consolidated financial statements. If such conditions persist longer or deteriorate further than expected, it is reasonably possible that the judgments and estimates could change, which may result in future impairments of assets among other effects. Going Concern In accordance with ASU No. 2014-15, Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern (Subtopic 205-40) , the Company has evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about its ability to continue as a going concern within one year after the date that the condensed consolidated financial statements are issued. Determining the extent to which conditions or events raise substantial doubt about the Company's ability to continue as a going concern and the extent to which mitigating plans sufficiently alleviate any such substantial doubt requires significant judgment and estimation by us. The Company's significant estimates related to this analysis may include identifying business factors such as size, growth and profitability used in the forecasted financial results and liquidity. Further, the Company makes assumptions about the probability that management's plans will be effectively implemented and alleviate substantial doubt and its ability to continue as a going concern. The Company believes that the estimated values used in its going concern analysis are based on reasonable assumptions. However, such assumptions are inherently uncertain and actual results could differ materially from those estimates. See Note 2, Liquidity and Going Concern , for more information about the Company's going concern assessment. Accounts Receivable and Allowance for Credit Losses, Returns, and Deductions Accounts receivable are customer obligations due under normal trade terms. Accounts receivables, less credit losses, reflects the net realizable value of receivables and approximates fair value. The Company accounts for accounts receivable, less credit losses, under ASU 2016-13, Financial Instruments – Credit Losses . The Company evaluated our accounts receivable and establish an allowance for credit loss based on a combination of factors. When aware that a specific customer has been impacted by circumstances such as bankruptcy filings or deterioration in the customer’s operating results or financial position, potentially making it unable to meet its financial obligations, the Company records a specific allowance for credit losses to reduce the related receivable to the amount the Company reasonably believes is collectible. The Company also records allowances for credit loss for all other customers based on a variety of factors, including the length of time the receivables are past due, historical collection experience, and an evaluation of current and projected economic conditions at the balance sheet date. Accounts receivables are charged off against the allowance for credit losses after we determine that the potential for recovery is remote. As of June 30, 2024, and December 31, 2023, the allowance for credit losses, returns and deductions totaled $ 1,358,874 and $ 1,638,039 , respectively. For the three months ended June 30, the allowance for credit losses, returns, and deductions consisted of the following: 2024 2023 Credit Losses Allowance Returns & Deductions Allowance Total Credit Losses Allowance Returns & Deductions Allowance Total Beginning balance, April 1 $ 968,845 $ 559,303 $ 1,528,148 $ 190,579 $ 364,193 $ 554,772 Provisions 68,311 94,259 162,570 6,987 469,078 476,065 Write-offs ( 331,844 ) — ( 331,844 ) — — — Ending balance, June 30 $ 705,312 $ 653,562 $ 1,358,874 $ 197,566 $ 833,271 $ 1,030,837 For the six months ended June 30, the allowance for credit losses, returns, and deductions consisted of the following: 2024 2023 Credit Losses Allowance Returns & Deductions Allowance Total Credit Losses Allowance Returns & Deductions Allowance Total Beginning balance, January 1 $ 815,236 $ 822,803 $ 1,638,039 $ 117,360 $ — $ 117,360 Provisions 221,920 ( 169,241 ) 52,679 80,206 833,271 913,477 Write-offs ( 331,844 ) — ( 331,844 ) — — — Ending balance, June 30 $ 705,312 $ 653,562 $ 1,358,874 $ 197,566 $ 833,271 $ 1,030,837 Concentration of Credit Risk The balance sheet items that potentially subject the Company to concentrations of credit risk are primarily cash and accounts receivable. The Company continuously evaluates the credit worthiness of its customers’ financial condition and generally does not require collateral. The Company maintains cash balances in bank accounts that may, at times, exceed Federal Deposit Insurance Corporation (“FDIC”) limits of $ 250,000 per institution. The Company incurred no losses from such accounts and management considers the risk of loss to be minimal. For the six months ended June 30, 2024 and 2023, the following customers represented more than 10% of consolidated sales. No vendors represented more than 10% of purchases. 2024 2023 Customer A 18 % 23 % Customer B 11 % 10 % Customer C 17 % — Customer F — 18 % As of June 30, 2024 and 2023, the following customers represented more than 10% of accounts receivable. No vendors represented more than 10% of the accounts payable balance. 2024 2023 Customer A 13 % 23 % Customer B 11 % 10 % Customer C 17 % — Customer D 14 % — Customer E — 10 % Revenue Recognition Policy The Company manufactures and markets a broad range of protein snack products through multiple distribution channels. The products are offered through branded and private label items. Generally, the Company considers all revenues as arising from contracts with customers. Revenue is recognized based on the five-step process outlined in Accounting Standards Codification ("ASC") 606, Revenue from Contracts with Customers : (1) Identification of the contract with a customer (2) Identification of the performance obligations in the contract (3) Determination of the transaction price (4) Allocation of the transaction price to the performance obligations in the contract (5) Recognition of revenue when, or as, the Company satisfies a performance obligation The Company’s revenue derived from the sale of branded and private label products is considered variable consideration as the contract includes discounts, rebates, incentives and other similar items. Generally, revenue is recognized at the point in time when the customer obtains control of the product, which may occur upon either shipment or delivery of the product. The payment terms of the Company’s contracts are generally net 30 to 60 days , although early pay discounts are offered to customers. The Company regularly experiences customer deductions from amounts invoiced due to product returns, product shortages, and delivery nonperformance penalty fees. This variable consideration is estimated using the expected value approach based on the Company’s historical experience, and it is recognized as a reduction to the transaction price in the same period that the related product sale is recognized. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products to customers. Revenue is recognized when the Company satisfies its performance obligations under the contract by transferring the promised product to its customer. The Company’s contracts generally do not include any material significant financing components. Performance Obligations The Company has elected the following practical expedients provided for in ASC 606 : (1) The Company has excluded from its transaction price all sales and similar taxes collected from its customers. (2) The Company has elected to recognize the incremental costs of obtaining a contract as an expense when incurred if the amortization period of the asset that the entity otherwise would have recognized is one year or less. (3) The Company has elected to account for shipping and handling activities that occur after control of the related good transfers as fulfillment activities instead of assessing such activities as performance obligations. (4) The portfolio approach has been elected by the Company as it expects any effects would not be materially different in application at the portfolio level compared with the application at an individual contract level. (5) The Company has elected not to disclose information about its remaining performance obligations for any contract that has an original expected duration of one year or less. Neither the type of good sold nor the location of sale significantly impacts the nature, amount, timing, or uncertainty of revenue and cash flows. Net Income (Loss) per Share The Company reports both basic and diluted earnings per share. Basic earnings per share is calculated based on the weighted average number of shares of common stock outstanding and excludes the dilutive effect of warrants, stock options, and other types of convertible securities. Diluted earnings per share is calculated based on the weighted average number of shares of common stock outstanding and the dilutive effect of stock options, warrants and other types of convertible securities are included in the calculation. Dilutive securities are excluded from the diluted earnings per share calculation if their effect is anti-dilutive, such as in periods where the Company would report a net loss. As of June 30, 2024 and 2023, the Company excluded the common stock equivalents summarized below, which entitle the holders thereof to ultimately acquire shares of common stock, from its calculation of earnings per share, as their effect would have been anti-dilutive. June 30, 2024 2023 Warrants/ Awards Number of Underlying Shares of Common Stock Warrants/ Awards Number of Underlying Shares of Common Stock Private Warrants 197,500 13,167 197,500 13,167 Public Warrants 10,800,000 720,000 10,800,000 720,000 Warrants - January 2022 Offering 10,294,118 686,275 10,294,118 686,275 Warrants - April 2023 Financing 7,964,550 530,970 7,964,550 530,970 Restricted Stock Awards - unvested 68,889 68,889 41,511 41,511 29,325,057 2,019,301 29,297,679 1,991,922 During the second quarter of 2024, the Company issued an aggregate of $ 1,515,152 in automatically converted notes. These notes w ill automatically convert into equity securities at the earlier of maturity or the next sale (or series of related sales) by the Company of its equity securities from which the Company receives gross proceeds of not less than $ 3,000,000 . See discussion of "Convertible Promissory Notes" in Note 6. The weighted average number of shares outstanding for purposes of per share calculations includes the Class V shares on as-exchanged basis. Income Taxes The Company accounts for income taxes pursuant to the asset and liability method of ASC 740, Income Taxes, which requires the Company to recognize current tax liabilities or receivables for the amount of taxes as estimated are payable or refundable for the current year, and deferred tax assets and liabilities for the expected future tax consequences attributable to temporary differences between the financial statement carrying amounts and their respective tax bases of assets and liabilities and the expected benefits of net operating loss and credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in operations in the period enacted. A valuation allowance is provided when it is more likely than not that a portion or all of a deferred tax asset will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income and the reversal of deferred tax liabilities during the period in which related temporary differences become deductible. On July 20, 2021 (the “Closing Date”), the Company completed a business combination (the "Business Combination") pursuant to that certain Business Combination Agreement (the "Business Combination Agreement"). Under the terms of a Tax Receivable Agreement (the “TRA”) as part of the Business Combination Agreement, the Company generally will be required to pay to the Seller 85 % of the applicable cash savings, if any, in U.S. federal and state income tax based on its ownership in Andina Holdings, LLC that the Company is deemed to realize in certain circumstances as a result of the increases in tax basis and certain tax attributes resulting from the Business Combination as described below. This is accounted for in conjunction with the methods used to record income tax described above. The Company follows the provisions of ASC 740-10 related to the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements. ASC 740-10 prescribes a comprehensive model for the financial statement recognition, measurement, presentation and disclosure of uncertain tax positions taken or expected to be taken in income tax returns. The benefit of tax positions taken or expected to be taken in the Company income tax returns is recognized in the financial statements if such positions are more likely than not of being sustained upon examination by taxing authorities. Differences between tax positions taken or expected to be taken in a tax return and the benefit recognized and measured pursuant to the interpretation are referred to as “unrecognized benefits”. A liability is recognized (or amount of net operating loss carryover or amount of tax refundable is reduced) for an unrecognized tax benefit because it represents an enterprise’s potential future obligation to the taxing authority for a tax position that was not recognized as a result of applying the provisions of ASC 740-10. Interest costs and related penalties related to unrecognized tax benefits are required to be calculated, if applicable. The Company's policy is to classify assessments, if any, for tax related interest and penalties as a component of income tax expense. As of June 30, 2024 , no liability for unrecognized tax benefits was required to be reported. The Company does not expect any significant changes in its unrecognized tax benefits in the next year. Tax Receivable Agreement In conjunction with the Business Combination, the Company entered into the TRA with Seller and Holdings. Pursuant to the TRA, the Company is required to pay Seller 85 % of the amount of savings, if any, in U.S. federal, state, local and foreign income tax that the Company actually realizes as a result of (a) tax basis adjustments resulting from taxable exchanges of Class B common units of Holdings and Class V common stock of the Company acquired by the Company in exchange for Class A common stock of the Company and (b) tax deductions in respect of portions of certain payments made under the TRA. All such payments to the Seller are the obligations of the Company. As of June 30, 2024 , there have been 386,530 shares of Class B common units of Holdings and Class V common stock of the Company exchanged for an equal number of shares of Class A common stock of the Company. The Company has not recognized any change to the deferred tax asset for changes in tax basis, as the asset is not more-likely-than-not to be realized. Additionally, the Company has not recognized the TRA liability as it is not probable that the TRA payments would be paid based on the Company's historical loss position and would not be payable until the company realizes tax benefit. Fair Value of Financial Instruments The Company’s financial instruments consist primarily of cash, accounts receivable, accounts payable, a line of credit, promissory notes payable and long-term debt. The carrying amounts of cash, accounts receivable, accounts payable, and promissory notes payable approximate their respective fair values because of the short-term maturities or expected settlement date of these instruments. The line of credit has variable interest rates the Company believes reflect current market rates for notes of this nature. The Company believes the current carrying value of long-term debt approximates its fair value because the terms are comparable to similar lending arrangements in the marketplace. Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC 815. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date. Recent Accounting Standards In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (“ASU 2023-07”), which requires public entities to disclose, on an annual and interim basis, significant segment expenses that are regularly provided to the chief operating decision maker and included within each reported measure of segment profit or loss. All public entities will be required to report segment information in accordance with the new guidance starting in annual periods beginning after December 15, 2023. The Company is determining the impact of ASU 2023-07 on its financial statements. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”), which enhances the transparency and decision usefulness of income tax disclosures by requiring; (1) consistent categories and greater disaggregation of information in the rate reconciliation and (2) income taxes paid disaggregated by jurisdiction. It also includes certain other amendments to improve the effectiveness of income tax disclosures. For public business entities, the standard is effective for annual periods beginning after December 15, 2024. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. The Company is determining the impact of ASU 2023-09 on its financial statements. |
Inventory
Inventory | 6 Months Ended |
Jun. 30, 2024 | |
Inventory Disclosure [Abstract] | |
Inventory | Note 4 - Inventory As of June 30, 2024, and December 31, 2023, inventory consisted of the following: June 30, December 31, Raw materials $ 1,540,581 $ 1,475,657 Work in process 960,382 703,117 Finished goods 2,300,409 3,021,205 Total Inventory $ 4,801,372 $ 5,199,979 Reserves for inventory obsolescence are recorded as necessary to reduce obsolete inventory to estimated net realizable value or to specifically reserve for obsolete inventory. Sales of previously reserved inventory net of write-downs and write-offs for the three and six months ended June 30, 2024 was $ 3,115 and $ 14,904 , respectively . Sales of previously reserved inventory net of write-downs and write-offs for the three and six months ended June 30, 2023 was $ 4,402 and $ 65,328 , respectively . |
Line of Credit
Line of Credit | 6 Months Ended |
Jun. 30, 2024 | |
Debt Disclosure [Abstract] | |
Line of Credit | Note 5 - Line of Credit On September 28, 2022, certain subsidiaries of the Company entered into an Invoice Purchase and Security Agreement (together with an Inventory Finance Rider thereto, the “PSA”) with Alterna Capital Solutions LLC (the “Lender”) providing for (a) the purchase by the Lender of certain of the subsidiaries’ accounts receivable, and (b) financing based upon a percentage of the value of the subsidiaries’ inventory. Pursuant to the PSA, the subsidiaries agree to sell eligible accounts receivable to the Lender for an amount equal to the face amount of each account receivable less a reserve percentage. The maximum amount potentially available to be deployed by the Lender at any given time is $ 8,000,000 , which may be increased to an amount up to $ 20,000,000 . Pursuant to the Inventory Finance Rider to the RSA, the subsidiaries may request advances from time to time based upon the value of the subsidiaries’ inventory. Such advances bear interest at the current prime rate plus 2.25 % and are required to be repaid at any time the aggregate outstanding amount of such advances exceed a designated percentage of the value of such inventory. The interest rate as of June 30, 2024 and December 31, 2023 was 10.75 %. The PSA provides for the payment of fees by the subsidiaries and includes customary representations and warranties, indemnification provisions, covenants and events of default. Subject in some cases to cure periods, amounts outstanding under the PSA may be accelerated for typical defaults including, but not limited to, the failure to make when due payments, the failure to perform any covenant, the inaccuracy of representations and warranties, the occurrence of debtor-relief proceedings and the occurrence of liens against the purchased accounts receivable and collateral. The subsidiaries have granted the Lender a security interest in all of their respective personal property to secure their obligations under the PSA; provided that the Lender has a first priority security interest in the Subsidiaries’ accounts receivable, payment intangibles and inventory. A named executive officer of the Company granted the Lender a security interest in certain personal property owned by the named executive officer to further secure the Company's obligations under the PSA. The PSA provides for an initial twenty-four ( 24 ) month term, followed by automatic annual renewal terms unless the subsidiaries provide written notice pursuant to the PSA prior to the end of any term. During March 2024, the PSA was amended to extend the initial term twenty-four ( 24 ) months after the date of the amendment, followed by automatic annual renewal terms unless the Company or the Lender provide written notice pursuant to the PSA prior to the end of any term. As of June 30, 2024 and December 31, 2023, $ 4,218,155 and $ 3,716,914 , respectively, was borrowed under the financing agreement. The Company recognized approximately $ 188,459 and $ 373,037 in interest expense for the three and six months ended June 30, 2024, respectively. The Company recognized approximately $ 124,032 and $ 211,631 in interest expense for the three and six months ended June 30, 2023 , respectively. The amount remaining available under the PSA is $ 3,800,000 . |
Debt
Debt | 6 Months Ended |
Jun. 30, 2024 | |
Debt Disclosure [Abstract] | |
Debt | Note 6 - Debt As of June 30, 2024 and December 31, 2023, long-term debt consisted of the following: 2024 2023 Revenue Loan and Security Agreement, net of debt issuance costs $ 3,733,918 $ 3,791,950 Broken Stone Agreement 19,775 19,775 Total long-term debt 3,753,693 3,811,725 Less: current portion ( 422,615 ) ( 335,636 ) Total long-term debt, net of current portion $ 3,331,078 $ 3,476,089 As of June 30, 2024 and December 31, 2023, short-term borrowings and current portion of long-term debt consisted of the following: 2024 2023 Invoice Purchase and Security Agreement, net of debt issuance costs $ 4,168,800 $ 3,568,295 Promissory Notes, net of debt premium and debt issuance costs 7,020,733 4,089,000 Commercial Premium Finance Agreement — 269,894 Current portion of long-term obligations 422,615 335,636 Total short-term borrowings and current portion of long-term debt $ 11,612,148 $ 8,262,825 Outstanding as of June 30, 2024 Revenue Loan and Security Agreement On September 28, 2022, the Company entered into a Revenue Loan and Security Agreement (the “Loan Agreement”) with Decathlon Alpha V, L.P. The Company was advanced $ 4,000,000 upon execution of the Loan Agreement. The Loan Agreement requires monthly payments, calculated as a percentage of the Company’s revenue from the previous month (subject to an annual payment cap) with all outstanding advances and the interest (as defined in the Loan Agreement) being due at maturity on June 13, 2027 (unless accelerated upon a change of control or the occurrence of other events of default). Interest does not accrue on advance(s) pursuant to the Loan Agreement, rather a minimum amount of interest (as defined in the Loan Agreement) is due pursuant to the terms of the Loan Agreement. The Loan Agreement further provides for the payment of fees by the Company and includes customary representations and warranties, indemnification provisions, covenants and events of default. Subject in some cases to cure periods, amounts outstanding and otherwise due under the Loan Agreement may be accelerated for typical defaults including, but not limited to, the failure to make when due payments, the failure to perform any covenant, the inaccuracy of representations and warranties, and the occurrence of debtor-relief proceedings. The advances are secured by all property of the Company and is guaranteed by the Company and certain of the Company’s Subsidiaries. The Company has accounted for the loan facility as debt in accordance with ASC 470-10-25-2 and use the effective interest rate method to estimate the timing and amount of future cash flows in accordance with ASC 835-30. The current effective interest rate is 11.7 %. As of June 30, 2024 and December 31, 2023, the balance on this loan was $ 3,795,820 and $ 3,864,175 , respectively. The Company recognized $ 154,607 and $ 231,839 i n interest expense for the three and six months ended June 30, 2024, respectively. The Company recognized $ 109,589 and $ 227,662 in interest expense for the three and six months ended June 30, 2023, respectively. No amount remained available under the Loan Agreement. Promissory Notes On April 19, 2023 , the Company issued an aggregate of $ 4,089,000 in principal amount of secured promissory notes (the “Notes”) to select accredited investors (the “Lenders”). The aggregate principal amount of the Notes is inclusive of $ 1,175,000 from related parties (the "Related Party Notes"). The Notes accrue interest annually at a rate of 12 % and are secured by a security interest on substantially all the assets of the Company that is subordinate to the security interests of the Company’s existing first and second lien lenders. Each Lender that purchased Notes received a warrant (the “Warrants”) to purchase 1/15th of one share of the Company’s Class A common stock for each $ 0.5134 of principal amount of the Notes, for an aggregate of 7,964,550 warrants convertible to 530,970 shares of Class A common stock. The aggregate amount of the Warrants is inclusive of 2,288,664 warrants convertible to 152,577 shares of Class A common stock associated with the Related Party Notes. The Company has accounted for the Notes as debt in accordance with ASC 470-10-25 and uses the effective interest rate method to estimate the timing and amount of future cash flows in accordance with ASC 835-30. The current effective interest rate is 12.0 %. As of June 30, 2024 and December 31, 2023 , the outstanding balance on the Notes was $ 4,089,000 of which $ 1,175,000 was due to related parties. In accordance with ASC 470-20-25-2, the Company allocated the proceeds between the Notes and Warrants based on their relative fair values. The allocation resulted in a discount to the Notes of $ 1,374,631 that was amortized over the initial term of the Notes. During January 2024, the Notes were amended to extend the maturity date of the Notes from December 31, 2023 to the earlier of (i) December 31, 2024 , or (ii) the closing of the next sale or series of related sales by the Company of its equity securities from which the Company receives gross proceeds of not less than $ 3.0 million, excluding proceeds from the warrants held by the Lenders and the Company’s at the market equity facility with Craig-Hallum Capital Group LLC. As consideration for the Final Lender’s entry into the Amendment, the Company (i) reduced the exercise price on the outstanding warrants issued to the lenders in April 2023 from $ 0.5134 per 1/15th of one share to $ 0.1833 per 1/15th of one share and (ii) agreed to issue shares of Class A common stock as payment in full for interest accrued on the Notes held through December 31, 2023 (at a value of $ 2.75 per share). The Company issued an aggregate of 53,559 shares of Class A common stock (at a value of $ 2.75 per share) to certain electing lenders as payment in full for interest accrued through December 31, 2023 on the Notes held by the electing lenders. The value of the accrued interest satisfied by the payment of 53,559 shares of Class A common stock to the electing lenders was $ 147,287 . The Company evaluated the amendment under ASC 470-50, “ Debt - Modification and Extinguishment ”, and concluded that the extension of the maturity date and modification of the exercise price of the Warrants resulted in significant and consequential changes to the economic substance of the debt and thus resulted in accounting for these modifications as an extinguishment of the debt. There were no unamortized deferred debt costs or debt discount at the time of the amendment. This Company recorded a loss on the extinguishment of the debt in the amount of $ 334,511 during the six months ended June 30, 2024. The Company recognized approximately $ 122,334 and $ 244,668 in interest expense for the three and six months ended June 30, 2024, respectively. The Company recognized approximately $ 532,988 in interest expense inclusive of debt discount amortization of $ 386,615 for the three and six months ended June 30, 2023. Convertible Promissory Notes During the second quarter of 2024, the Company issued an aggregate of $ 2,954,545 in principal amount of unsecured promissory notes (the “Convertible Notes”) to select accredited investors. The aggregate principal amount of the Convertible Notes is inclusive of $ 1,702,020 from related parties. The Convertible Notes were issued with an original issue discount of 1 %, accrue interest annually at a rate of 12 % and will mature on December 31, 2024 . The Convertible Notes will automatically convert into the securities issued in the next sale (or series of related sales) by the Company of its equity securities, following the date of the Convertible Notes, from which the Company receives gross proceeds of not less than $ 3,000,000 . Certain of the Convertible Notes that remain unconverted at maturity will automatically convert into a new class of preferred shares. During the second quarter of 2024, the Company issued an aggregate of $ 505,051 in the automatically converted notes and amended $ 1,010,101 of the original notes to automatically convert upon maturity. The Company has accounted for the Convertible Notes as debt in accordance with ASC 470-10-25 and uses the effective interest rate method to estimate the timing and amount of future cash flows in accordance with ASC 835-30. The current effective interest rate is 12.0 %. As of June 30, 2024 , the outstanding balance on the Convertible Notes was $ 2,931,733 of which $ 1,688,751 was due to related parties. The Company recognized approximately $ 63,897 in interest expense for the three and six months ended June 30, 2024. Future minimum principal payments, on debt as of June 30, 2024 are as follows: 2024 $ 11,447,170 2025 539,067 2026 1,057,722 2027 2,033,338 $ 15,077,297 |
Income Taxes
Income Taxes | 6 Months Ended |
Jun. 30, 2024 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Note 7 - Income Taxes The Company’s sole material asset is Andina Holdings, LLC, which is treated as a partnership for U.S. federal income tax purposes and for purposes of certain state and local income taxes. Andina Holdings, LLC owns 100 % of Stryve Foods, LLC which is treated as a disregarded entity for the U.S. federal income tax purposes. Stryve Foods Holdings, LLC's net taxable income and any related tax credits are passed through to its members and are included in the members’ tax returns, even though such net taxable income or tax credits may not have actually been distributed. The income tax burden on the earnings taxed to the non-controlling interests is not reported by the Company in its condensed consolidated financial statements under GAAP. As a result, the Company’s effective tax rate is expected to differ materially from the statutory rate. ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of June 30, 2024 and December 31, 2023 , no liability for unrecognized tax benefits was required to be reported and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position over the next twelve months. The Company currently estimates its annual effective income tax rate t o be ( 0.1102 )%, which differs from the federal rate of 21 % primarily due to tax benefit related to income passed through to non-controlling interest, increase in valuation allowances, and state and local income taxes. The Company has reported income tax expense of $ 900 and $ 9,898 for t he three and six months ended June 30, 2024. The Company has reported income tax benefit of $ 12,854 and $ 9,523 for t he three and six months ended June 30, 2023. Tax Receivable Agreement Liability In conjunction with the Business Combination, the Company also entered into a TRA with the Seller and Holdings. Pursuant to the TRA, the Company is required to pay the Seller 85 % of the amount of savings, if any, in United States federal, state, local and foreign income tax that the Company actually realizes as a result of (a) tax basis adjustments resulting from taxable exchanges of Class B common units of Holdings and Class V common stock of the Company acquired by the Company in exchange for Class A common stock of the Company and (b) tax deductions in respect of portions of certain payments made under the TRA. All such payments to the Seller are the obligations of the Company. As of June 30, 2024 , there have been 386,530 shares of Class B common units of Holdings and Class V common stock of the Company exchanged for an equal number of shares of Class A common stock of the Company. The estimation of liability under the TRA is by its nature imprecise and subject to significant assumptions regarding the amount and timing of future taxable income. As of June 30, 2024 , the Company has recorded a full valuation allowance against its net deferred tax assets as the realizability of the tax benefit is not at the more likely than not threshold. Since the benefit has not been recorded, the Company has determined that the TRA liability is no t probable and therefore no TRA liability existed as of June 30, 2024. |
Shareholders_ Equity
Shareholders’ Equity | 6 Months Ended |
Jun. 30, 2024 | |
Equity [Abstract] | |
Shareholders' Equity | Note 8 - Shareholders’ Equity The Company’s Amended and Restated Certificate of Incorporation (“Charter”) authorizes the issuance of 425,000,000 shares, of which 400,000,000 shares are Class A common stock, par value $ 0.0001 per share, 15,000,000 shares of Class V common stock, par value $ 0.0001 per share, and 10,000,000 shares of preferred stock, par value $ 0.0001 per share. Warrants Public Warrants The Company has outstanding 10,997,500 warrants convertible into 733,166 shares of Class A common stock that were issued prior to the Business Combination, of which 10,800,000 convertible into 720,000 shares of Class A common stock are referred to as public warrants and 197,500 convertible into 13,166 shares of Class A common stock are Private Warrants. Each warrant represents the right to purchase 1/15th of a share of the Company’s Class A common stock at a price of $ 172.50 per whole share. The warrants expire on July 20, 2026 . The Company may call the public warrants for redemption (but not the Private Warrants), in whole and not in part, at a price of $ .01 per Public Warrant: ● at any time while the public warrants are exercisable, ● upon not less than 30 days’ prior written notice of redemption to each public warrant holder, ● if, and only if, the reported last sale price of shares of Class A common stock equals or exceeds $ 270.00 per share, for any 20 trading days within a 30-trading day period ending on the third business day prior to the notice of redemption to public warrant holders, and ● if, and only if, there is a current registration statement in effect with respect to shares of Class A common stock underlying such public warrants at the time of redemption and for the entire 30-day trading period referred to above and continuing each day thereafter until the date of redemption. The right to exercise will be forfeited unless the warrants are exercised prior to the date specified in the notice of redemption. Private Warrants The Company has agreed that so long as the Private Warrants are still held by its initial shareholders or their affiliates, it will not redeem such Private Warrants and will allow the holders to exercise such Private Warrants on a cashless basis (even if a registration statement covering shares of Class A common stock issuable upon exercise of such warrants is not effective). As of June 30, 2024, there were 197,500 Private Warrants outstanding. April 2023 Warrants On April 19, 2023 , the Company issued certain lenders warrants (the “April 2023 Warrants”) to purchase 1/15th of a share of the Company’s Class A common stock for each $ 0.5134 of principal amount of the Notes, for an aggregate of 7,964,550 warrants convertible to 530,970 shares of Class A common stock. The aggregate amount of the April 2023 Warrants is inclusive of 2,288,664 warrants convertible to 152,577 shares of Class A common stock associated with related parties. Each warrant is exercisable immediately, has an exercise price per share of Class A common stock equal to $ 7.701 per whole share and will expire three years and three months from the date of issuance and may be exercised on a cashless basis if a registration statement registering the resale of the shares issuable upon exercise is not effective. The exercise price was subsequently reduced to $ 2.75 per whole share. See Note 6 for further discussion. The warrant holder will be prohibited, subject to certain exceptions, from exercising the Warrants for shares of the Company’s Class A common stock to the extent that immediately prior to or after giving effect to such exercise, the warrant holder, together with its affiliates and other attribution parties, would own more than 4.99 % or 9.99 %, as applicable, of the total number of shares of the Company’s Class A common stock then issued and outstanding, which percentage may be changed at the warrant holders’ election to a higher or lower percentage not in excess of 9.99 % upon 61 days’ notice to the Company. The Company agreed to use commercially reasonable efforts to register the shares of Class A common stock underlying the Warrants within 60 days and to have the registration statement declared effective within 30 days thereafter. As of June 30, 2024 , there were 7,964,550 April 2023 Warrants outstanding exercisable for up to 530,970 shares of Class A common stock. Stryve Foods, Inc. 2021 Omnibus Incentive Plan (the “Incentive Plan”) The Incentive Plan allows the Company to grant stock options, restricted stock unit awards and other awards at levels determined appropriate by its board of directors and/or compensation committee. The Incentive Plan also allows the Company to use a broad array of equity incentives and performance cash incentives in order to secure and retain the services of its employees, directors and consultants, and to provide long-term incentives that align the interests of its employees, directors and consultants with the interests of its stockholders. The Incentive Plan is administered by the Company’s board of directors or its compensation committee, or any other committee or subcommittee or one or more of its officers to whom authority has been delegated (collectively, the “Administrator”). The Administrator has the authority to interpret the Incentive Plan and award agreements entered into with respect to the Incentive Plan; to make, change and rescind rules and regulations relating to the Incentive Plan; to make changes to, or reconcile any inconsistency in, the Incentive Plan or any award agreement covering an award; and to take any other actions needed to administer the Incentive Plan. The Incentive Plan permits the Administrator to grant stock options, stock appreciation rights (“SARs”), performance shares, performance units, shares of Class A common stock, restricted stock, restricted stock units (“RSUs”), cash incentive awards, dividend equivalent units, or any other type of award permitted under the Incentive Plan. The Administrator may grant any type of award to any participant it selects, but only employees of the Company or its subsidiaries may receive grants of incentive stock options within the meaning of Section 422 of the Internal Revenue Code. Awards may be granted alone or in addition to, in tandem with, or (subject to the repricing prohibition described below) in substitution for any other award (or any other award granted under another plan of the Company or any affiliate, including the plan of an acquired entity). The number of shares reserved for issuance under the Incentive Plan will be reduced on the date of the grant of any award by the maximum number of shares, if any, with respect to which such award is granted. However, an award that may be settled solely in cash will not deplete the Incentive Plan’s share reserve at the time the award is granted. If (a) an award expires, is canceled, or terminates without issuance of shares or is settled in cash, (b) the Administrator determines that the shares granted under an award will not be issuable because the conditions for issuance will not be satisfied, (c) shares are forfeited under an award, (d) shares are issued under any award and the Company reacquires them pursuant to its reserved rights upon the issuance of the shares, (e) shares are tendered or withheld in payment of the exercise price of an option or as a result of the net settlement of outstanding stock appreciation rights or (f) shares are tendered or withheld to satisfy federal, state or local tax withholding obligations, then those shares are added back to the reserve and may again be used for new awards under the Incentive Plan. However, shares added back to the reserve pursuant to clauses (d), (e) or (f) in the preceding sentence may not be issued pursuant to incentive stock options. As of June 30, 2024 , the Company had 412,960 shares of Class A common stock available for future issuance under the Incentive Plan. Beginning in 2025, the number of shares available under the Incentive Plan is subject to an automatic annual increase in the number of shares authorized equal to the lesser of (a) 4 % of the Company’s total shares of Class A common stock outstanding on December 31st of the immediately preceding year and (b) a number of shares of Class A common stock determined by the Board that is less than (a). |
Stock Based Compensation
Stock Based Compensation | 6 Months Ended |
Jun. 30, 2024 | |
Share-Based Payment Arrangement [Abstract] | |
Stock Based Compensation | Note 9 - Stock Based Compensation The Company's stock-based awards that result in compensation expense consist of restricted stock units (RSUs) and restricted stock awards (RSAs). As of June 30, 2024 , the Company had 412,960 shares available for grant under its stock plans. As of June 30, 2024, the total unrecognized compensation cost related to all unvested stock-based compensation awar ds was $ 1,602,458 a nd is expected to be recognized over the next four years . RSUs generally vest over three years and RSAs generally vest from one to four years . Restricted Stock Units (RSUs) The following table summarizes the Company's RSU activity: Nonvested Restricted Stock Units Weighted Average Restricted Stock Award Date Fair Value Units Per Share Restricted Stock at January 1, 2024 193,205 $ 5.18 Granted 57,500 1.46 Forfeited ( 250 ) 2.58 Vested ( 19,306 ) 7.79 Restricted Stock at June 30, 2024 231,149 $ 4.04 The fair value of RSUs is determined based on the closing market price of the Company's stock on the grant date. The fair value of RSUs with a market condition is determined based on a Monte Carlo valuation simulation. Restricted Stock Awards (RSAs) The following table summarizes the Company's RSA activity: Nonvested Restricted Stock Awards Weighted Average Weighted Average Restricted Stock Award Date Fair Value Director Award Date Fair Value Awards Per Share Stock Awards Per Share Restricted Stock at January 1, 2024 52,778 $ 16.09 5,000 $ 12.45 Granted — — 52,500 1.25 Forfeited — — — — Vested ( 15,139 ) 18.19 ( 26,250 ) — Restricted Stock at June 30, 2024 37,639 $ 15.24 31,250 $ 3.04 The fair value of RSAs is determined based on the closing market price of the Company's stock on the grant date. Stock Based Compensation Expense The Company has a long-term incentive plan under which the Compensation Committee of the Board of Directors has the authority to grant share-based awards to Company employees and non-employees. Stock based compensation costs associated with employee RSU and RSA grants are recorded as a separate component of salaries and wages on the condensed consolidated statements of operations. For the three and six months ended June 30, 2024, $ 252,310 and $ 498,749 , respectively, were recorded in salaries and wages. For the three and six months ended June 30, 2023, $ 245,525 and $ 397,214 , respectively, were recorded in salaries and wages. Stock based compensation costs associated with non-employee RSU and RSA grants are recorded as a separate component of selling expenses on the condensed consolidated statements of operations. For the three and six months ended June 30, 2024, $ 24,116 and $ 48,052 , respectively, were recorded in selling expenses. For the three and six months ended June 30, 2023, $ 186,916 and $ 220,751 , respectively, were recorded in selling expenses. Stock based compensation expense for service-based awards that contain a graded vesting schedule is recognized on a straight-line basis. The Company accounts for forfeitures when they occur. |
Related Party Transactions
Related Party Transactions | 6 Months Ended |
Jun. 30, 2024 | |
Related Party Transactions [Abstract] | |
Related Party Transactions | Note 10 - Related Party Transactions Sale and Leaseback . On May 26, 2021 , the Company entered into a Purchase and Sale Agreement with OK Biltong Facility, LLC (“Buyer”), an entity controlled by a member of the Company’s board of directors, pursuant to which the parties consummated a sale and leaseback transaction (the “Sale and Leaseback Transaction”) of the Company’s manufacturing facility and the surrounding property in Madill, Oklahoma (the “Real Property”) for a total purchase price of $ 7,500,000 . In connection with the consummation of the Sale and Leaseback Transaction, the Company entered into a lease agreement (the “Lease Agreement”) with Buyer pursuant to which the Company leased back the Real Property from Buyer for an initial term of twelve ( 12 ) years unless earlier terminated or extended in accordance with the terms of the Lease Agreement. Under the Lease Agreement, the Company’s financial obligations include base rent of approximately $ 60,000 per month, which rent will increase on an annual basis at two percent ( 2 %) over the initial term and two-and-a-half percent ( 2.5 %) during any extension term. The Company is also responsible for all monthly expenses related to the leased facility, including insurance premiums, taxes and other expenses, such as utilities. Under the Lease Agreement, the Company has three (3) options to extend the term of the lease by five ( 5 ) years for each such option and a one-time right and option to purchase the Real Property at a price that escalates over time and, if Buyer decides to sell the Real Property, the Company has a right of first refusal to purchase the Real Property on the same terms offered to any third party. The Company determined that the sale and leaseback transaction contained continuing involvement and thus used the financing method consistent with ASC 842. The transfer did not qualify as a sale; hence it is considered a "failed" sale and both parties account for it as a financing transaction. Accordingly, a financing obligation related to the operating lease in the amount of the sale price ($ 7,500,000 ) has been booked and the corresponding assets on the balance sheet are maintained. Under the finance method, rental payments are applied as amortization and/or interest expense on the financing obligation as appropriate using an assumed interest rate. The Company is accounting for these as interest only payments because the Company's incremental cost to borrow when applied to the financing obligation is greater than the rental payments under the Lease Agreement. The Company recognized interest expense of $ 187,265 and $ 377,162 duri ng the three and six months ended June 30, 2024, respectively. The Company recognized interest expense of $ 183,593 and $ 367,185 duri ng the three and six months ended June 30, 2023, respectively. Promissory Notes. On April 19, 2023 , the Company issued an aggregate of $ 1,175,000 in Related Party Notes. The Related Party Notes accrue interest annually at a rate of 12 % and will mature upon the earlier of (i) December 31, 2024 , or (ii) the closing of the next sale (or series of related sales) by the Company of its equity securities (other than pursuant to warrants described below), following the date of the Related Party Notes, from which the Company receives gross proceeds of not less than $ 3,000,000 . The Related Party Notes are secured by a security interest on substantially all the assets of the Company that is subordinate to the security interests of the Company’s existing first and second lien lenders. See Note 6 for further discussion on the Related Party Notes. Each related party lender that purchased Related Party Notes received a warrant (the “April 2023 Warrants”) to purchase 1/15th of a share of the Company’s Class A common stock for each $ 0.1833 of principal amount of the Related Party Notes, for an aggregate of 2,288,664 April 2023 Warrants convertible to 152,577 shares of Class A common stock. Each April 2023 Warrant is exercisable immediately, has an exercise price per share of Class A common stock equal to $ 2.75 and will expire three years and three months from the date of issuance and may be exercised on a cashless basis if a registration statement registering the resale of the shares issuable upon exercise is not effective. See Note 8 for further discussion on the April 2023 Warrants. Convertible Promissory Notes. During the second quarter of 2024, the Company issued an aggregate of $ 1,702,020 in Related Party Convertible Notes. The Related Party Convertible Notes were issued with an original issue discount of 1 %, accrue interest annually at a rate of 12 % and will automatically convert in the securities issued in the next sale (or series of related sales) by the Company of its equity securities, following the date of the Convertible Notes, from which the Company receives gross proceeds of not less than $ 3,000,000 . See Note 6 for further discussion on the Related Party Convertible Notes. Other . During the six months ended June 30, 2024 and 2023 , the Company did no t purch ase goods from an entity controlled by a member of the Company’s Board of Directors (the "Related Party Manufacturer"). The balance owed to the Related Party Manufacturer as of June 30, 2024 and December 31, 2023 was $ 807 . The Company previously had note receivables due from certain directors, officers and employees of the Company. The note receivables and the accrued interest was forgiven in connection with the Business Combination on July 20, 2021. The forgiveness of these note receivables resulted in non-cash compensation expense to the related parties for the year ended December 31, 2021. The Company agreed to reimburse the related parties for their portion of income taxes related to the non-cash compensation. As of June 30, 2024 and December 31, 2023 , the balance owed to the related parties was $ 282,830 and $ 278,771 , respectively. In connection with the PSA, a named executive officer of the Company granted the Lender a security interest in certain personal property owned by the named executive officer to further secure the Company's obligations under the PSA. See further discussion at Note 5. As consideration for granting the security interest to the Lender, the Company agreed to pay the name executive officer an annual fee of 7.2 % of the guaranteed balance not to exceed $ 100,000 and reimbursement of out of pocket expenses. The balance owed to the name executive officer as of June 30, 2024 and December 31, 2023 was $ 72,000 and $ 100,000 , respectively. |
Commitments and Contingencies
Commitments and Contingencies | 6 Months Ended |
Jun. 30, 2024 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Note 11 - Commitments and Contingencies Litigation The Company may be a party to routine claims brought against it in the ordinary course of business or stemming from its liquidity constraints. After consulting with legal counsel, the Company does not believe that the outcome of any such pending litigation will have a material adverse effect on its financial condition or results of operations. However, as is inherent in legal proceedings, there is a risk that an unpredictable decision adverse to the Company could be reached. The Company records legal costs associated with loss contingencies as incurred. Settlements are accrued when, and if, they become probable and estimable. Registration Rights Agreements The Company is a party to various registration rights agreements with certain stockholders where it may be required to register securities for such stockholders in certain circumstances. |
Subsequent Events
Subsequent Events | 6 Months Ended |
Jun. 30, 2024 | |
Subsequent Events [Abstract] | |
Subsequent Events | Note 12 - Subsequent Events The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the condensed financial statements were issued. Based upon this review, other than as described below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the condensed financial statements. Convertible Notes In July 2024, the Company issued an aggregate of $ 353,535 in principal amount of unsecured convertible promissory notes (the “July 2024 Convertible Notes”) for $ 350,000 in proceeds to select accredited investors to fund growth in working capital and general operations. The July 2024 Convertible Notes were issued with an original issue discount of 1 %, accrue interest annually at a rate of 12 % and will mature on December 31, 2024 . The July 2024 Convertible Notes will automatically convert into equity securities at the earlier of maturity or the next sale (or series of related sales) by the Company of its equity securities from which the Company receives gross proceeds of not less than $ 3,000,000 . |
Significant Accounting Polici_2
Significant Accounting Policies (Policies) | 6 Months Ended |
Jun. 30, 2024 | |
Accounting Policies [Abstract] | |
Basis of Presentation | Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States ("GAAP") for interim financial information and in accordance with the rules and regulations of the Securities and Exchange Commission ("SEC"). Accordingly, these interim financial statements do not include all information and footnotes required under GAAP for complete financial statements. In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments, consisting of only normal recurring adjustments, necessary for a fair statement of results of operations, balance sheet, cash flows, and shareholders' equity for the periods presented. The unaudited condensed consolidated results of operations for the interim periods presented are not necessarily indicative of results for the full year. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in the Company’s Annual Report filed on Form 10-K for the year ended December 31, 2023 . The Company’s condensed consolidated financial statements include the accounts of the Company and its subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. Certain information and footnote disclosures normally included in the annual consolidated financial statements prepared in accordance with GAAP have been condensed or omitted. |
Use of Estimates | Use of Estimates The preparation of the condensed consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Accounting estimates and assumptions discussed herein are those that management considers to be the most critical to an understanding of the condensed consolidated financial statements because they inherently involve significant judgments and uncertainties. Estimates are used for, but not limited to revenue recognition, allowance for credit losses and customer allowances, inventory valuation, impairments of goodwill and long-lived assets, incremental borrowing rate for leases, and valuation allowances for deferred tax assets. All of these estimates reflect management’s judgment about current economic and market conditions and their effects based on information available as of the date of these consolidated financial statements. If such conditions persist longer or deteriorate further than expected, it is reasonably possible that the judgments and estimates could change, which may result in future impairments of assets among other effects. |
Going Concern | Going Concern In accordance with ASU No. 2014-15, Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern (Subtopic 205-40) , the Company has evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about its ability to continue as a going concern within one year after the date that the condensed consolidated financial statements are issued. Determining the extent to which conditions or events raise substantial doubt about the Company's ability to continue as a going concern and the extent to which mitigating plans sufficiently alleviate any such substantial doubt requires significant judgment and estimation by us. The Company's significant estimates related to this analysis may include identifying business factors such as size, growth and profitability used in the forecasted financial results and liquidity. Further, the Company makes assumptions about the probability that management's plans will be effectively implemented and alleviate substantial doubt and its ability to continue as a going concern. The Company believes that the estimated values used in its going concern analysis are based on reasonable assumptions. However, such assumptions are inherently uncertain and actual results could differ materially from those estimates. See Note 2, Liquidity and Going Concern , for more information about the Company's going concern assessment. |
Accounts Receivable and Allowance for Credit Losses, Returns, and Deductions | Accounts Receivable and Allowance for Credit Losses, Returns, and Deductions Accounts receivable are customer obligations due under normal trade terms. Accounts receivables, less credit losses, reflects the net realizable value of receivables and approximates fair value. The Company accounts for accounts receivable, less credit losses, under ASU 2016-13, Financial Instruments – Credit Losses . The Company evaluated our accounts receivable and establish an allowance for credit loss based on a combination of factors. When aware that a specific customer has been impacted by circumstances such as bankruptcy filings or deterioration in the customer’s operating results or financial position, potentially making it unable to meet its financial obligations, the Company records a specific allowance for credit losses to reduce the related receivable to the amount the Company reasonably believes is collectible. The Company also records allowances for credit loss for all other customers based on a variety of factors, including the length of time the receivables are past due, historical collection experience, and an evaluation of current and projected economic conditions at the balance sheet date. Accounts receivables are charged off against the allowance for credit losses after we determine that the potential for recovery is remote. As of June 30, 2024, and December 31, 2023, the allowance for credit losses, returns and deductions totaled $ 1,358,874 and $ 1,638,039 , respectively. For the three months ended June 30, the allowance for credit losses, returns, and deductions consisted of the following: 2024 2023 Credit Losses Allowance Returns & Deductions Allowance Total Credit Losses Allowance Returns & Deductions Allowance Total Beginning balance, April 1 $ 968,845 $ 559,303 $ 1,528,148 $ 190,579 $ 364,193 $ 554,772 Provisions 68,311 94,259 162,570 6,987 469,078 476,065 Write-offs ( 331,844 ) — ( 331,844 ) — — — Ending balance, June 30 $ 705,312 $ 653,562 $ 1,358,874 $ 197,566 $ 833,271 $ 1,030,837 For the six months ended June 30, the allowance for credit losses, returns, and deductions consisted of the following: 2024 2023 Credit Losses Allowance Returns & Deductions Allowance Total Credit Losses Allowance Returns & Deductions Allowance Total Beginning balance, January 1 $ 815,236 $ 822,803 $ 1,638,039 $ 117,360 $ — $ 117,360 Provisions 221,920 ( 169,241 ) 52,679 80,206 833,271 913,477 Write-offs ( 331,844 ) — ( 331,844 ) — — — Ending balance, June 30 $ 705,312 $ 653,562 $ 1,358,874 $ 197,566 $ 833,271 $ 1,030,837 |
Concentration of Credit Risk | Concentration of Credit Risk The balance sheet items that potentially subject the Company to concentrations of credit risk are primarily cash and accounts receivable. The Company continuously evaluates the credit worthiness of its customers’ financial condition and generally does not require collateral. The Company maintains cash balances in bank accounts that may, at times, exceed Federal Deposit Insurance Corporation (“FDIC”) limits of $ 250,000 per institution. The Company incurred no losses from such accounts and management considers the risk of loss to be minimal. For the six months ended June 30, 2024 and 2023, the following customers represented more than 10% of consolidated sales. No vendors represented more than 10% of purchases. 2024 2023 Customer A 18 % 23 % Customer B 11 % 10 % Customer C 17 % — Customer F — 18 % As of June 30, 2024 and 2023, the following customers represented more than 10% of accounts receivable. No vendors represented more than 10% of the accounts payable balance. 2024 2023 Customer A 13 % 23 % Customer B 11 % 10 % Customer C 17 % — Customer D 14 % — Customer E — 10 % |
Revenue Recognition Policy | Revenue Recognition Policy The Company manufactures and markets a broad range of protein snack products through multiple distribution channels. The products are offered through branded and private label items. Generally, the Company considers all revenues as arising from contracts with customers. Revenue is recognized based on the five-step process outlined in Accounting Standards Codification ("ASC") 606, Revenue from Contracts with Customers : (1) Identification of the contract with a customer (2) Identification of the performance obligations in the contract (3) Determination of the transaction price (4) Allocation of the transaction price to the performance obligations in the contract (5) Recognition of revenue when, or as, the Company satisfies a performance obligation The Company’s revenue derived from the sale of branded and private label products is considered variable consideration as the contract includes discounts, rebates, incentives and other similar items. Generally, revenue is recognized at the point in time when the customer obtains control of the product, which may occur upon either shipment or delivery of the product. The payment terms of the Company’s contracts are generally net 30 to 60 days , although early pay discounts are offered to customers. The Company regularly experiences customer deductions from amounts invoiced due to product returns, product shortages, and delivery nonperformance penalty fees. This variable consideration is estimated using the expected value approach based on the Company’s historical experience, and it is recognized as a reduction to the transaction price in the same period that the related product sale is recognized. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products to customers. Revenue is recognized when the Company satisfies its performance obligations under the contract by transferring the promised product to its customer. The Company’s contracts generally do not include any material significant financing components. Performance Obligations The Company has elected the following practical expedients provided for in ASC 606 : (1) The Company has excluded from its transaction price all sales and similar taxes collected from its customers. (2) The Company has elected to recognize the incremental costs of obtaining a contract as an expense when incurred if the amortization period of the asset that the entity otherwise would have recognized is one year or less. (3) The Company has elected to account for shipping and handling activities that occur after control of the related good transfers as fulfillment activities instead of assessing such activities as performance obligations. (4) The portfolio approach has been elected by the Company as it expects any effects would not be materially different in application at the portfolio level compared with the application at an individual contract level. (5) The Company has elected not to disclose information about its remaining performance obligations for any contract that has an original expected duration of one year or less. Neither the type of good sold nor the location of sale significantly impacts the nature, amount, timing, or uncertainty of revenue and cash flows. |
Net Income (Loss) per Share | Net Income (Loss) per Share The Company reports both basic and diluted earnings per share. Basic earnings per share is calculated based on the weighted average number of shares of common stock outstanding and excludes the dilutive effect of warrants, stock options, and other types of convertible securities. Diluted earnings per share is calculated based on the weighted average number of shares of common stock outstanding and the dilutive effect of stock options, warrants and other types of convertible securities are included in the calculation. Dilutive securities are excluded from the diluted earnings per share calculation if their effect is anti-dilutive, such as in periods where the Company would report a net loss. As of June 30, 2024 and 2023, the Company excluded the common stock equivalents summarized below, which entitle the holders thereof to ultimately acquire shares of common stock, from its calculation of earnings per share, as their effect would have been anti-dilutive. June 30, 2024 2023 Warrants/ Awards Number of Underlying Shares of Common Stock Warrants/ Awards Number of Underlying Shares of Common Stock Private Warrants 197,500 13,167 197,500 13,167 Public Warrants 10,800,000 720,000 10,800,000 720,000 Warrants - January 2022 Offering 10,294,118 686,275 10,294,118 686,275 Warrants - April 2023 Financing 7,964,550 530,970 7,964,550 530,970 Restricted Stock Awards - unvested 68,889 68,889 41,511 41,511 29,325,057 2,019,301 29,297,679 1,991,922 During the second quarter of 2024, the Company issued an aggregate of $ 1,515,152 in automatically converted notes. These notes w ill automatically convert into equity securities at the earlier of maturity or the next sale (or series of related sales) by the Company of its equity securities from which the Company receives gross proceeds of not less than $ 3,000,000 . See discussion of "Convertible Promissory Notes" in Note 6. The weighted average number of shares outstanding for purposes of per share calculations includes the Class V shares on as-exchanged basis. |
Income Taxes | Income Taxes The Company accounts for income taxes pursuant to the asset and liability method of ASC 740, Income Taxes, which requires the Company to recognize current tax liabilities or receivables for the amount of taxes as estimated are payable or refundable for the current year, and deferred tax assets and liabilities for the expected future tax consequences attributable to temporary differences between the financial statement carrying amounts and their respective tax bases of assets and liabilities and the expected benefits of net operating loss and credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in operations in the period enacted. A valuation allowance is provided when it is more likely than not that a portion or all of a deferred tax asset will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income and the reversal of deferred tax liabilities during the period in which related temporary differences become deductible. On July 20, 2021 (the “Closing Date”), the Company completed a business combination (the "Business Combination") pursuant to that certain Business Combination Agreement (the "Business Combination Agreement"). Under the terms of a Tax Receivable Agreement (the “TRA”) as part of the Business Combination Agreement, the Company generally will be required to pay to the Seller 85 % of the applicable cash savings, if any, in U.S. federal and state income tax based on its ownership in Andina Holdings, LLC that the Company is deemed to realize in certain circumstances as a result of the increases in tax basis and certain tax attributes resulting from the Business Combination as described below. This is accounted for in conjunction with the methods used to record income tax described above. The Company follows the provisions of ASC 740-10 related to the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements. ASC 740-10 prescribes a comprehensive model for the financial statement recognition, measurement, presentation and disclosure of uncertain tax positions taken or expected to be taken in income tax returns. The benefit of tax positions taken or expected to be taken in the Company income tax returns is recognized in the financial statements if such positions are more likely than not of being sustained upon examination by taxing authorities. Differences between tax positions taken or expected to be taken in a tax return and the benefit recognized and measured pursuant to the interpretation are referred to as “unrecognized benefits”. A liability is recognized (or amount of net operating loss carryover or amount of tax refundable is reduced) for an unrecognized tax benefit because it represents an enterprise’s potential future obligation to the taxing authority for a tax position that was not recognized as a result of applying the provisions of ASC 740-10. Interest costs and related penalties related to unrecognized tax benefits are required to be calculated, if applicable. The Company's policy is to classify assessments, if any, for tax related interest and penalties as a component of income tax expense. As of June 30, 2024 , no liability for unrecognized tax benefits was required to be reported. The Company does not expect any significant changes in its unrecognized tax benefits in the next year. |
Tax Receivable Agreement | Tax Receivable Agreement In conjunction with the Business Combination, the Company entered into the TRA with Seller and Holdings. Pursuant to the TRA, the Company is required to pay Seller 85 % of the amount of savings, if any, in U.S. federal, state, local and foreign income tax that the Company actually realizes as a result of (a) tax basis adjustments resulting from taxable exchanges of Class B common units of Holdings and Class V common stock of the Company acquired by the Company in exchange for Class A common stock of the Company and (b) tax deductions in respect of portions of certain payments made under the TRA. All such payments to the Seller are the obligations of the Company. As of June 30, 2024 , there have been 386,530 shares of Class B common units of Holdings and Class V common stock of the Company exchanged for an equal number of shares of Class A common stock of the Company. The Company has not recognized any change to the deferred tax asset for changes in tax basis, as the asset is not more-likely-than-not to be realized. Additionally, the Company has not recognized the TRA liability as it is not probable that the TRA payments would be paid based on the Company's historical loss position and would not be payable until the company realizes tax benefit. |
Fair Value of Financial Instruments | Fair Value of Financial Instruments The Company’s financial instruments consist primarily of cash, accounts receivable, accounts payable, a line of credit, promissory notes payable and long-term debt. The carrying amounts of cash, accounts receivable, accounts payable, and promissory notes payable approximate their respective fair values because of the short-term maturities or expected settlement date of these instruments. The line of credit has variable interest rates the Company believes reflect current market rates for notes of this nature. The Company believes the current carrying value of long-term debt approximates its fair value because the terms are comparable to similar lending arrangements in the marketplace. |
Derivative Financial Instruments | Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC 815. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date. |
Recent Accounting Standards | Recent Accounting Standards In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (“ASU 2023-07”), which requires public entities to disclose, on an annual and interim basis, significant segment expenses that are regularly provided to the chief operating decision maker and included within each reported measure of segment profit or loss. All public entities will be required to report segment information in accordance with the new guidance starting in annual periods beginning after December 15, 2023. The Company is determining the impact of ASU 2023-07 on its financial statements. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”), which enhances the transparency and decision usefulness of income tax disclosures by requiring; (1) consistent categories and greater disaggregation of information in the rate reconciliation and (2) income taxes paid disaggregated by jurisdiction. It also includes certain other amendments to improve the effectiveness of income tax disclosures. For public business entities, the standard is effective for annual periods beginning after December 15, 2024. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. The Company is determining the impact of ASU 2023-09 on its financial statements. |
Significant Accounting Polici_3
Significant Accounting Policies (Tables) | 6 Months Ended |
Jun. 30, 2024 | |
Accounting Policies [Abstract] | |
Schedule of Allowance for Credit Losses, Returns, and Deductions | For the three months ended June 30, the allowance for credit losses, returns, and deductions consisted of the following: 2024 2023 Credit Losses Allowance Returns & Deductions Allowance Total Credit Losses Allowance Returns & Deductions Allowance Total Beginning balance, April 1 $ 968,845 $ 559,303 $ 1,528,148 $ 190,579 $ 364,193 $ 554,772 Provisions 68,311 94,259 162,570 6,987 469,078 476,065 Write-offs ( 331,844 ) — ( 331,844 ) — — — Ending balance, June 30 $ 705,312 $ 653,562 $ 1,358,874 $ 197,566 $ 833,271 $ 1,030,837 For the six months ended June 30, the allowance for credit losses, returns, and deductions consisted of the following: 2024 2023 Credit Losses Allowance Returns & Deductions Allowance Total Credit Losses Allowance Returns & Deductions Allowance Total Beginning balance, January 1 $ 815,236 $ 822,803 $ 1,638,039 $ 117,360 $ — $ 117,360 Provisions 221,920 ( 169,241 ) 52,679 80,206 833,271 913,477 Write-offs ( 331,844 ) — ( 331,844 ) — — — Ending balance, June 30 $ 705,312 $ 653,562 $ 1,358,874 $ 197,566 $ 833,271 $ 1,030,837 |
Summary of Customers Concentrations | For the six months ended June 30, 2024 and 2023, the following customers represented more than 10% of consolidated sales. No vendors represented more than 10% of purchases. 2024 2023 Customer A 18 % 23 % Customer B 11 % 10 % Customer C 17 % — Customer F — 18 % As of June 30, 2024 and 2023, the following customers represented more than 10% of accounts receivable. No vendors represented more than 10% of the accounts payable balance. 2024 2023 Customer A 13 % 23 % Customer B 11 % 10 % Customer C 17 % — Customer D 14 % — Customer E — 10 % |
Schedule of Antidilutive Securities Excluded from Calculation of Earnings Per Share | As of June 30, 2024 and 2023, the Company excluded the common stock equivalents summarized below, which entitle the holders thereof to ultimately acquire shares of common stock, from its calculation of earnings per share, as their effect would have been anti-dilutive. June 30, 2024 2023 Warrants/ Awards Number of Underlying Shares of Common Stock Warrants/ Awards Number of Underlying Shares of Common Stock Private Warrants 197,500 13,167 197,500 13,167 Public Warrants 10,800,000 720,000 10,800,000 720,000 Warrants - January 2022 Offering 10,294,118 686,275 10,294,118 686,275 Warrants - April 2023 Financing 7,964,550 530,970 7,964,550 530,970 Restricted Stock Awards - unvested 68,889 68,889 41,511 41,511 29,325,057 2,019,301 29,297,679 1,991,922 |
Inventory (Tables)
Inventory (Tables) | 6 Months Ended |
Jun. 30, 2024 | |
Inventory Disclosure [Abstract] | |
Schedule of Inventory | As of June 30, 2024, and December 31, 2023, inventory consisted of the following: June 30, December 31, Raw materials $ 1,540,581 $ 1,475,657 Work in process 960,382 703,117 Finished goods 2,300,409 3,021,205 Total Inventory $ 4,801,372 $ 5,199,979 |
Debt (Tables)
Debt (Tables) | 6 Months Ended |
Jun. 30, 2024 | |
Debt Disclosure [Abstract] | |
Schedule of Long-Term Debt | As of June 30, 2024 and December 31, 2023, long-term debt consisted of the following: 2024 2023 Revenue Loan and Security Agreement, net of debt issuance costs $ 3,733,918 $ 3,791,950 Broken Stone Agreement 19,775 19,775 Total long-term debt 3,753,693 3,811,725 Less: current portion ( 422,615 ) ( 335,636 ) Total long-term debt, net of current portion $ 3,331,078 $ 3,476,089 |
Schedule of Short-term Borrowings and Current Portion of Long-term Debt | As of June 30, 2024 and December 31, 2023, short-term borrowings and current portion of long-term debt consisted of the following: 2024 2023 Invoice Purchase and Security Agreement, net of debt issuance costs $ 4,168,800 $ 3,568,295 Promissory Notes, net of debt premium and debt issuance costs 7,020,733 4,089,000 Commercial Premium Finance Agreement — 269,894 Current portion of long-term obligations 422,615 335,636 Total short-term borrowings and current portion of long-term debt $ 11,612,148 $ 8,262,825 |
Future Minimum Principal Payments on Debt | Future minimum principal payments, on debt as of June 30, 2024 are as follows: 2024 $ 11,447,170 2025 539,067 2026 1,057,722 2027 2,033,338 $ 15,077,297 |
Stock Based Compensation (Table
Stock Based Compensation (Tables) | 6 Months Ended |
Jun. 30, 2024 | |
Share-Based Payment Arrangement [Abstract] | |
Summary of Restricted Stock Unit and Restricted Stock Awards Activity | The following table summarizes the Company's RSU activity: Nonvested Restricted Stock Units Weighted Average Restricted Stock Award Date Fair Value Units Per Share Restricted Stock at January 1, 2024 193,205 $ 5.18 Granted 57,500 1.46 Forfeited ( 250 ) 2.58 Vested ( 19,306 ) 7.79 Restricted Stock at June 30, 2024 231,149 $ 4.04 The following table summarizes the Company's RSA activity: Nonvested Restricted Stock Awards Weighted Average Weighted Average Restricted Stock Award Date Fair Value Director Award Date Fair Value Awards Per Share Stock Awards Per Share Restricted Stock at January 1, 2024 52,778 $ 16.09 5,000 $ 12.45 Granted — — 52,500 1.25 Forfeited — — — — Vested ( 15,139 ) 18.19 ( 26,250 ) — Restricted Stock at June 30, 2024 37,639 $ 15.24 31,250 $ 3.04 |
Organization and Description _2
Organization and Description of Business - Additional Information (Details) | 6 Months Ended |
Jun. 30, 2024 $ / shares | |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |
Reverse stock split conversion ratio | 0.0667 |
Class A Common Stock [Member] | |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |
Common stock, par value | $ 0.0001 |
Class V Common Stock [Member] | |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |
Common stock, par value | $ 0.0001 |
Liquidity and Going Concern - A
Liquidity and Going Concern - Additional Information (Details) - USD ($) | 3 Months Ended | 6 Months Ended | |||||||||
Jun. 30, 2024 | Mar. 31, 2024 | Jun. 30, 2023 | Mar. 31, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | Jul. 31, 2024 | Dec. 31, 2023 | Dec. 31, 2022 | Sep. 28, 2022 | Sep. 27, 2022 | |
Net loss | $ (2,961,747) | $ (3,928,514) | $ (4,308,817) | $ (4,642,556) | $ (6,890,261) | $ (8,951,372) | |||||
Cash used in operating activities | (3,706,608) | $ (5,212,681) | |||||||||
Working capital (deficit) | (11,700,000) | (11,700,000) | $ (7,400,000) | ||||||||
Invoice Purchase and Security Agreement [Member] | |||||||||||
Additional borrowing capacity | 3,800,000 | 3,800,000 | |||||||||
Invoice Purchase and Security Agreement [Member] | Alterna Capital Solutions LLC [Member] | |||||||||||
Line of credit facility drawn | 4,218,155 | 4,218,155 | $ 3,716,914 | ||||||||
Maximum borrowing capacity | $ 8,000,000 | ||||||||||
Additional borrowing capacity | 3,800,000 | 3,800,000 | |||||||||
Invoice Purchase and Security Agreement [Member] | Alterna Capital Solutions LLC [Member] | Maximum [Member] | |||||||||||
Maximum borrowing capacity | $ 20,000,000 | $ 8,000,000 | |||||||||
Revenue Loan And Security Agreement [Member] | |||||||||||
Debt instrument, remaining balance | 0 | 0 | |||||||||
Revenue Loan And Security Agreement [Member] | Decathlon Alpha IV, L.P. [Member] | |||||||||||
Debt instrument, principal amount | $ 4,000,000 | ||||||||||
Line of credit facility drawn | $ 4,000,000 | ||||||||||
Unsecured Convertible Promissory Notes [Member] | |||||||||||
Debt instrument, principal amount | 2,954,545 | 2,954,545 | |||||||||
Unsecured Convertible Promissory Notes [Member] | Related Party [Member] | |||||||||||
Debt instrument, principal amount | $ 1,702,020 | $ 1,702,020 | |||||||||
Unsecured Convertible Promissory Notes [Member] | Subsequent Event [Member] | |||||||||||
Debt instrument, principal amount | $ 353,535 |
Significant Accounting Polici_4
Significant Accounting Policies - Additional Information (Details) - USD ($) | 3 Months Ended | 6 Months Ended | ||||||
Jun. 30, 2024 | Jun. 30, 2024 | Mar. 31, 2024 | Dec. 31, 2023 | Jun. 30, 2023 | Apr. 19, 2023 | Mar. 31, 2023 | Dec. 31, 2022 | |
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||||
Allowance for credit losses, returns and deductions | $ 1,358,874 | $ 1,358,874 | $ 1,528,148 | $ 1,638,039 | $ 1,030,837 | $ 554,772 | $ 117,360 | |
Revenue practical expedient, incremental cost of obtaining contract [true/false] | true | |||||||
Unrecognized tax benefits | 0 | $ 0 | $ 0 | |||||
Percentage of savings required to be paid to the seller | 85% | |||||||
Cash, FDIC insured amount | 250,000 | $ 250,000 | ||||||
Unsecured Convertible Promissory Notes [Member] | ||||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||||
Debt instrument, principal amount | 2,954,545 | 2,954,545 | ||||||
Unsecured Convertible Promissory Notes [Member] | Automatically Converted Notes at Earlier of Maturity or Next Sale of Equity Securities [Member] | ||||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||||
Debt instrument, principal amount | 1,515,152 | $ 1,515,152 | ||||||
Secured Promissory Notes [Member] | ||||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||||
Debt instrument, principal amount | $ 4,089,000 | |||||||
Minimum [Member] | ||||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||||
Contract with customers payment terms | 30 days | |||||||
Minimum [Member] | Unsecured Convertible Promissory Notes [Member] | ||||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||||
Gross proceeds from issuance of notes | $ 3,000,000 | |||||||
Maximum [Member] | ||||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||||
Contract with customers payment terms | 60 days | |||||||
Tax Receivable Agreement [Member] | ||||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||||
Percentage of savings required to be paid to the seller | 85% | |||||||
Class B common units of holdings and class V common stock of the company | ||||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||||
Exchanged number of shares | 386,530 | 386,530 |
Significant Accounting Polici_5
Significant Accounting Policies - Additional Information (Details 1) | Jun. 30, 2024 |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-07-01 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Remaining performance obligation expected to be recognized period | 1 year |
Significant Accounting Polici_6
Significant Accounting Policies - Schedule of Allowance for Credit Losses, Returns, and Deductions (Details) - USD ($) | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | |
Allowance for Credit Loss [Abstract] | ||||
Beginning balance | $ 968,845 | $ 190,579 | $ 815,236 | $ 117,360 |
Provisions related to credit losses allowance | 68,311 | 6,987 | 221,920 | 80,206 |
Write-offs related to credit losses allowance | (331,844) | (331,844) | ||
Ending balance | 705,312 | 197,566 | 705,312 | 197,566 |
Beginning balance related to returns and deductions allowance | 559,303 | 364,193 | 822,803 | |
Provisions related to returns and deductions allowance | 94,259 | 469,078 | (169,241) | 833,271 |
Ending balance related to returns and deductions allowance | 653,562 | 833,271 | 653,562 | 833,271 |
Beginning balance, Total | 1,528,148 | 554,772 | 1,638,039 | 117,360 |
Provisions related to allowance for credit losses, returns, and deductions | 162,570 | 476,065 | 52,679 | 913,477 |
Write-offs related to allowance for credit losses, returns, and deductions | (331,844) | (331,844) | ||
Ending balance, Total | $ 1,358,874 | $ 1,030,837 | $ 1,358,874 | $ 1,030,837 |
Significant Accounting Polici_7
Significant Accounting Policies - Summary of Customers and Vendor Concentrations (Details) - Customer Concentration Risk [Member] | 6 Months Ended | |
Jun. 30, 2024 | Jun. 30, 2023 | |
Customer A [Member] | Consolidated Sales and Purchases [Member] | ||
Concentration Risk [Line Items] | ||
Concentration percentage | 18% | 23% |
Customer A [Member] | Accounts Receivable [Member] | ||
Concentration Risk [Line Items] | ||
Concentration percentage | 13% | 23% |
Customer B [Member] | Consolidated Sales and Purchases [Member] | ||
Concentration Risk [Line Items] | ||
Concentration percentage | 11% | 10% |
Customer B [Member] | Accounts Receivable [Member] | ||
Concentration Risk [Line Items] | ||
Concentration percentage | 11% | 10% |
Customer C [Member] | Consolidated Sales and Purchases [Member] | ||
Concentration Risk [Line Items] | ||
Concentration percentage | 17% | |
Customer C [Member] | Accounts Receivable [Member] | ||
Concentration Risk [Line Items] | ||
Concentration percentage | 17% | |
Customer D [Member] | Accounts Receivable [Member] | ||
Concentration Risk [Line Items] | ||
Concentration percentage | 14% | |
Customer E [Member] | Accounts Receivable [Member] | ||
Concentration Risk [Line Items] | ||
Concentration percentage | 10% | |
Customer F [Member] | Consolidated Sales and Purchases [Member] | ||
Concentration Risk [Line Items] | ||
Concentration percentage | 18% |
Significant Accounting Polici_8
Significant Accounting Policies - Schedule of Antidilutive Securities Excluded from Calculation of Earnings Per Share (Details) - shares | 6 Months Ended | |
Jun. 30, 2024 | Jun. 30, 2023 | |
Warrants/Awards [Member] | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Anti-dilutive securities excluded from calculation of earnings per share | 29,325,057 | 29,297,679 |
Number of Underlying Shares of Common Stock [Member] | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Anti-dilutive securities excluded from calculation of earnings per share | 2,019,301 | 1,991,922 |
Private Warrants [Member] | Warrants/Awards [Member] | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Anti-dilutive securities excluded from calculation of earnings per share | 197,500 | 197,500 |
Private Warrants [Member] | Number of Underlying Shares of Common Stock [Member] | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Anti-dilutive securities excluded from calculation of earnings per share | 13,167 | 13,167 |
Public Warrants [Member] | Warrants/Awards [Member] | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Anti-dilutive securities excluded from calculation of earnings per share | 10,800,000 | 10,800,000 |
Public Warrants [Member] | Number of Underlying Shares of Common Stock [Member] | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Anti-dilutive securities excluded from calculation of earnings per share | 720,000 | 720,000 |
Warrants - January 2022 Offering [Member] | Warrants/Awards [Member] | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Anti-dilutive securities excluded from calculation of earnings per share | 10,294,118 | 10,294,118 |
Warrants - January 2022 Offering [Member] | Number of Underlying Shares of Common Stock [Member] | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Anti-dilutive securities excluded from calculation of earnings per share | 686,275 | 686,275 |
Warrants - April 2023 Financing [Member] | Warrants/Awards [Member] | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Anti-dilutive securities excluded from calculation of earnings per share | 7,964,550 | 7,964,550 |
Warrants - April 2023 Financing [Member] | Number of Underlying Shares of Common Stock [Member] | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Anti-dilutive securities excluded from calculation of earnings per share | 530,970 | 530,970 |
Restricted Stock Awards - Unvested [Member] | Warrants/Awards [Member] | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Anti-dilutive securities excluded from calculation of earnings per share | 68,889 | 41,511 |
Restricted Stock Awards - Unvested [Member] | Number of Underlying Shares of Common Stock [Member] | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Anti-dilutive securities excluded from calculation of earnings per share | 68,889 | 41,511 |
Inventory - Schedule of Invento
Inventory - Schedule of Inventory (Details) - USD ($) | Jun. 30, 2024 | Dec. 31, 2023 |
Inventory Disclosure [Abstract] | ||
Raw materials | $ 1,540,581 | $ 1,475,657 |
Work in process | 960,382 | 703,117 |
Finished goods | 2,300,409 | 3,021,205 |
Total Inventory | $ 4,801,372 | $ 5,199,979 |
Inventory - Additional Informat
Inventory - Additional Information (Details) - USD ($) | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | |
Inventory Disclosure [Abstract] | ||||
Sales of previously reserved inventory net of write-down | $ 3,115 | $ 4,402 | $ 14,904 | $ 65,328 |
Line of Credit - Additional Inf
Line of Credit - Additional Information (Details) - Invoice Purchase and Security Agreement [Member] - USD ($) | 1 Months Ended | 3 Months Ended | 6 Months Ended | |||||
Sep. 28, 2022 | Mar. 31, 2024 | Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | Dec. 31, 2023 | Sep. 27, 2022 | |
Line of Credit Facility [Line Items] | ||||||||
Remaining borrowing available | $ 3,800,000 | $ 3,800,000 | ||||||
Alterna Capital Solutions LLC [Member] | ||||||||
Line of Credit Facility [Line Items] | ||||||||
Maximum borrowing capacity | $ 8,000,000 | |||||||
Line of credit | $ 4,218,155 | $ 4,218,155 | $ 3,716,914 | |||||
Line of credit, interest rate at period end | 10.75% | 10.75% | 10.75% | |||||
Line of credit initial term | 24 months | 24 months | ||||||
Interest expense | $ 188,459 | $ 124,032 | $ 373,037 | $ 211,631 | ||||
Remaining borrowing available | $ 3,800,000 | $ 3,800,000 | ||||||
Alterna Capital Solutions LLC [Member] | Maximum [Member] | ||||||||
Line of Credit Facility [Line Items] | ||||||||
Maximum borrowing capacity | $ 20,000,000 | $ 8,000,000 | ||||||
Alterna Capital Solutions LLC [Member] | Prime Rate [Member] | ||||||||
Line of Credit Facility [Line Items] | ||||||||
Line of credit, interest rate | 2.25% |
Debt - Schedule of Long-Term De
Debt - Schedule of Long-Term Debt (Details) - USD ($) | Jun. 30, 2024 | Dec. 31, 2023 |
Debt Instrument [Line Items] | ||
Long-term debt | $ 3,753,693 | $ 3,811,725 |
Less: current portion | (422,615) | (335,636) |
Total long-term debt, net of current portion | 3,331,078 | 3,476,089 |
Revenue Loan and Security Agreement, net of debt issuance costs [Member] | ||
Debt Instrument [Line Items] | ||
Long-term debt | 3,733,918 | 3,791,950 |
Broken Stone Agreement [Member] | ||
Debt Instrument [Line Items] | ||
Long-term debt | $ 19,775 | $ 19,775 |
Debt - Schedule of Short-term B
Debt - Schedule of Short-term Borrowings and Current Portion of Long-term Debt (Details) - USD ($) | Jun. 30, 2024 | Dec. 31, 2023 |
Debt Instrument [Line Items] | ||
Line of credit current | $ 4,168,800 | $ 3,568,295 |
Current portion of long-term obligations | 422,615 | 335,636 |
Total short-term borrowings and current portion of long-term debt | 11,612,148 | 8,262,825 |
Commercial Premium Finance Agreement [Member] | ||
Debt Instrument [Line Items] | ||
Short-term borrowings | 0 | 269,894 |
Promissory Notes, Net of Debt Premium and Debt Issuance Costs [Member] | ||
Debt Instrument [Line Items] | ||
Notes payable current | 7,020,733 | 4,089,000 |
Invoice Purchase and Security Agreement, net of debt issuance costs [Member] | ||
Debt Instrument [Line Items] | ||
Line of credit current | $ 4,168,800 | $ 3,568,295 |
Debt - Outstanding - Additional
Debt - Outstanding - Additional Information (Details) - USD ($) | 1 Months Ended | 3 Months Ended | 6 Months Ended | 9 Months Ended | |||||
Apr. 19, 2023 | Sep. 28, 2022 | Jan. 31, 2024 | Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | Sep. 30, 2023 | Dec. 31, 2023 | |
Debt Instrument [Line Items] | |||||||||
Debt instrument, principal amount due | $ 15,077,297 | $ 15,077,297 | |||||||
Discount to the notes being amortized | $ 1,335,997 | ||||||||
Loss on extinguishment of debt | 0 | 0 | 334,511 | $ 0 | |||||
April 2023 Warrants [Member] | |||||||||
Debt Instrument [Line Items] | |||||||||
Debt instrument, issuance date | Apr. 19, 2023 | ||||||||
Class A Common Stock [Member] | |||||||||
Debt Instrument [Line Items] | |||||||||
Warrant, exercise price per share | $ 0.5134 | ||||||||
Number of warrants exercised for shares of common stock | 530,970 | ||||||||
Aggregate warrants | 7,964,550 | ||||||||
Revenue Loan and Security Agreement [Member] | |||||||||
Debt Instrument [Line Items] | |||||||||
Debt instrument, remaining balance | 0 | 0 | |||||||
Interest expense | $ 154,607 | 109,589 | 231,839 | 227,662 | |||||
Unsecured Convertible Promissory Notes [Member] | |||||||||
Debt Instrument [Line Items] | |||||||||
Debt instrument, maturity date | Dec. 31, 2024 | ||||||||
Debt instrument, principal amount | $ 2,954,545 | $ 2,954,545 | |||||||
Debt instrument, interest rate | 12% | 12% | |||||||
Effective interest rate percentage | 12% | 12% | |||||||
Debt instrument, discount rate | 1% | ||||||||
Interest expense | $ 63,897 | $ 63,897 | |||||||
Outstanding debt | 2,931,733 | 2,931,733 | |||||||
Unsecured Convertible Promissory Notes [Member] | Minimum [Member] | |||||||||
Debt Instrument [Line Items] | |||||||||
Gross proceeds from issuance of notes | 3,000,000 | ||||||||
Unsecured Convertible Promissory Notes [Member] | Automatically Converted Notes [Member] | |||||||||
Debt Instrument [Line Items] | |||||||||
Debt instrument, principal amount | 505,051 | 505,051 | |||||||
Unsecured Convertible Promissory Notes [Member] | Notes Automatically Convert upon Maturity [Member] | |||||||||
Debt Instrument [Line Items] | |||||||||
Debt instrument, principal amount | $ 1,010,101 | $ 1,010,101 | |||||||
Secured Promissory Notes [Member] | |||||||||
Debt Instrument [Line Items] | |||||||||
Debt instrument, maturity date | Dec. 31, 2023 | ||||||||
Debt instrument extended maturity date | Dec. 31, 2024 | ||||||||
Debt instrument, principal amount | $ 4,089,000 | ||||||||
Debt instrument, interest rate | 12% | ||||||||
Effective interest rate percentage | 12% | 12% | |||||||
Interest expense | $ 122,334 | 532,988 | $ 244,668 | 532,988 | |||||
Debt instrument, issuance date | Apr. 19, 2023 | ||||||||
Discount to the notes being amortized | 1,374,631 | ||||||||
Amortization of debt discount | $ 386,615 | $ 386,615 | |||||||
Secured Promissory Notes [Member] | Minimum [Member] | |||||||||
Debt Instrument [Line Items] | |||||||||
Gross proceeds from issuance of notes | $ 3,000,000 | ||||||||
Secured Promissory Notes [Member] | Class A Common Stock [Member] | |||||||||
Debt Instrument [Line Items] | |||||||||
Sale of unit price per share | $ 2.75 | ||||||||
Secured Promissory Notes [Member] | Class A Common Stock [Member] | April 2023 Warrants [Member] | |||||||||
Debt Instrument [Line Items] | |||||||||
Aggregate shares issued to certain electing lenders as payment in full for interest accrued | 53,559 | ||||||||
Accrued interest satisfied by payment to electing lenders amount | $ 147,287 | ||||||||
Promissory Note [Member] | |||||||||
Debt Instrument [Line Items] | |||||||||
Unamortized deferred debt costs | 0 | ||||||||
Loss on extinguishment of debt | 334,511 | ||||||||
Decathlon Alpha V, L.P. [Member] | Revenue Loan and Security Agreement [Member] | |||||||||
Debt Instrument [Line Items] | |||||||||
Debt instrument, maturity date | Jun. 13, 2027 | ||||||||
Debt instrument, principal amount | $ 4,000,000 | ||||||||
Debt instrument, principal amount due | $ 3,795,820 | $ 3,795,820 | $ 3,864,175 | ||||||
Debt instrument, frequency of periodic payment | monthly | ||||||||
Effective interest rate percentage | 11.70% | 11.70% | |||||||
Certain Members of Management and Board of Directors [Member] | |||||||||
Debt Instrument [Line Items] | |||||||||
Debt instrument, principal amount | $ 4,089,000 | $ 4,089,000 | 4,089,000 | ||||||
Aggregate warrants | 2,288,664 | ||||||||
Certain Members of Management and Board of Directors [Member] | April 2023 Warrants [Member] | |||||||||
Debt Instrument [Line Items] | |||||||||
Number of warrants exercised for shares of common stock | 2,288,664 | ||||||||
Certain Members of Management and Board of Directors [Member] | Class A Common Stock [Member] | |||||||||
Debt Instrument [Line Items] | |||||||||
Debt instrument, principal amount | $ 1,175,000 | $ 1,175,000 | $ 1,175,000 | ||||||
Number of warrants exercised for shares of common stock | 152,577 | 152,577 | |||||||
Certain Members of Management and Board of Directors [Member] | Secured Promissory Notes [Member] | Class A Common Stock [Member] | April 2023 Warrants [Member] | |||||||||
Debt Instrument [Line Items] | |||||||||
Warrant, exercise price per share | $ 0.5134 | $ 0.1833 | |||||||
Related Party [Member] | Unsecured Convertible Promissory Notes [Member] | |||||||||
Debt Instrument [Line Items] | |||||||||
Debt instrument, principal amount | $ 1,702,020 | $ 1,702,020 | |||||||
Debt instrument, interest rate | 12% | 12% | |||||||
Debt instrument, discount rate | 1% | ||||||||
Outstanding debt | $ 1,688,751 | $ 1,688,751 | |||||||
Related Party [Member] | Unsecured Convertible Promissory Notes [Member] | Minimum [Member] | |||||||||
Debt Instrument [Line Items] | |||||||||
Gross proceeds from issuance of notes | $ 3,000,000 | ||||||||
Related Party [Member] | Secured Promissory Notes [Member] | |||||||||
Debt Instrument [Line Items] | |||||||||
Debt instrument, principal amount | $ 1,175,000 |
Debt - Future Minimum Principal
Debt - Future Minimum Principal Payments on Debt (Details) | Jun. 30, 2024 USD ($) |
Maturities of Long-Term Debt [Abstract] | |
2024 | $ 11,447,170 |
2025 | 539,067 |
2026 | 1,057,722 |
2027 | 2,033,338 |
Long-term Debt, Total | $ 15,077,297 |
Income Taxes - Additional Infor
Income Taxes - Additional Information (Details) - USD ($) | 3 Months Ended | 6 Months Ended | |||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | Dec. 31, 2023 | |
Income Tax Contingency [Line Items] | |||||
Unrecognized tax benefits | $ 0 | $ 0 | $ 0 | ||
Accrued for interest and penalties | 0 | $ 0 | $ 0 | ||
Percentage of savings required to be paid to the seller | 85% | ||||
Effective income tax rate | (0.1102%) | ||||
Federal rate | 21% | ||||
Tax receivable agreement liability | 0 | $ 0 | |||
Income tax expense (benefit) | $ 900 | $ (12,854) | $ 9,898 | $ (9,523) | |
Class B common units of holdings and class V common stock of the company | |||||
Income Tax Contingency [Line Items] | |||||
Exchanged number of shares | 386,530 | 386,530 | |||
Stryve Foods, LLC [Member] | |||||
Income Tax Contingency [Line Items] | |||||
Ownership percentage | 100% | 100% |
Shareholders' Equity - Addition
Shareholders' Equity - Additional Information (Details) - USD ($) | 1 Months Ended | 6 Months Ended | ||
Apr. 19, 2023 | Jan. 31, 2024 | Jun. 30, 2024 | Dec. 31, 2023 | |
Subsidiary, Sale of Stock [Line Items] | ||||
Shares authorized | 425,000,000 | |||
Preferred Stock, shares authorized | 10,000,000 | 10,000,000 | ||
Preferred Stock, par value | $ 0.0001 | $ 0.0001 | ||
Warrants redemption price per share | $ 0.01 | |||
Warrants outstanding | $ 10,997,500 | |||
Shares issued price per share | $ 172.5 | |||
Warrants expiration | Jul. 20, 2026 | |||
Private Warrants [Member] | ||||
Subsidiary, Sale of Stock [Line Items] | ||||
Warrants outstanding | $ 197,500 | |||
Public Warrants [Member] | ||||
Subsidiary, Sale of Stock [Line Items] | ||||
Warrants outstanding | 10,800,000 | |||
April 2023 Warrants [Member] | ||||
Subsidiary, Sale of Stock [Line Items] | ||||
Warrants outstanding | $ 7,964,550 | |||
Debt instrument, issuance date | Apr. 19, 2023 | |||
April 2023 Warrants [Member] | Certain Members of Management and Board of Directors [Member] | ||||
Subsidiary, Sale of Stock [Line Items] | ||||
Number of warrants exercised for shares of common stock | 2,288,664 | |||
Secured Promissory Notes [Member] | ||||
Subsidiary, Sale of Stock [Line Items] | ||||
Debt instrument, issuance date | Apr. 19, 2023 | |||
Class A Common Stock [Member] | ||||
Subsidiary, Sale of Stock [Line Items] | ||||
Common stock, shares authorized | 400,000,000 | |||
Conversion of stock, shares issued | 733,166 | |||
Common stock, par value | $ 0.0001 | |||
Price per share | $ 270 | |||
Common stock reserved for future issuance | 412,960 | |||
Percentage of company shares | 4% | |||
Class A Common Stock [Member] | Private Warrants [Member] | ||||
Subsidiary, Sale of Stock [Line Items] | ||||
Conversion of stock, shares issued | 13,166 | |||
Class A Common Stock [Member] | Public Warrants [Member] | ||||
Subsidiary, Sale of Stock [Line Items] | ||||
Conversion of stock, shares issued | 720,000 | |||
Class A Common Stock [Member] | April 2023 Warrants [Member] | ||||
Subsidiary, Sale of Stock [Line Items] | ||||
Conversion of stock, shares issued | 530,970 | |||
Number of warrants exercised for shares of common stock | 7,964,550 | |||
Warrant offering term | 3 years 3 months | |||
Warrant, exercise price per share | $ 0.5134 | |||
Warrants outstanding exercisable | 530,970 | |||
Class A Common Stock [Member] | April 2023 Warrants [Member] | Certain Members of Management and Board of Directors [Member] | ||||
Subsidiary, Sale of Stock [Line Items] | ||||
Conversion of stock, shares issued | 152,577 | |||
Warrant, exercise price per share | $ 7.701 | |||
Class A Common Stock [Member] | Minimum [Member] | April 2023 Warrants [Member] | ||||
Subsidiary, Sale of Stock [Line Items] | ||||
Warrant holder, ownership percentage | 4.99% | |||
Class A Common Stock [Member] | Maximum [Member] | April 2023 Warrants [Member] | ||||
Subsidiary, Sale of Stock [Line Items] | ||||
Warrant holder, ownership percentage | 9.99% | |||
Class A Common Stock [Member] | Secured Promissory Notes [Member] | April 2023 Warrants [Member] | Certain Members of Management and Board of Directors [Member] | ||||
Subsidiary, Sale of Stock [Line Items] | ||||
Warrant exercise price decrease | $ 2.75 | |||
Class V Common Stock [Member] | ||||
Subsidiary, Sale of Stock [Line Items] | ||||
Common stock, shares authorized | 15,000,000 | |||
Common stock, par value | $ 0.0001 |
Stock Based Compensation - Addi
Stock Based Compensation - Additional Information (Details) - USD ($) | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Shares available for grant | 412,960 | 412,960 | ||
Selling expenses | $ 1,577,148 | $ 1,778,274 | $ 3,173,685 | $ 3,747,283 |
Unrecognized compensation cost | 1,602,458 | $ 1,602,458 | ||
Unrecognized compensation cost expected to be recognized | 4 years | |||
Non-employee RSU and RSA grants [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Selling expenses | 24,116 | 186,916 | $ 48,052 | 220,751 |
Salaries and Wages [Member] | Employee RSU and RSA grants [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Stock based compensation expense | $ 252,310 | $ 245,525 | $ 498,749 | $ 397,214 |
Restricted Stock Units (RSUs) [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Vesting period | 3 years | |||
Restricted Stock Award RSA [Member] | Minimum [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Vesting period | 1 year | |||
Restricted Stock Award RSA [Member] | Maximum [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Vesting period | 4 years |
Stock Based Compensation - Summ
Stock Based Compensation - Summary of Restricted Stock Unit and Restricted Stock Awards Activity (Details) | 6 Months Ended |
Jun. 30, 2024 $ / shares shares | |
Restricted Stock Units (RSUs) [Member] | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Number of shares, Beginning Balance | 193,205 |
Number of shares, Granted | 57,500 |
Number of shares, Forfeited | (250) |
Number of shares, Vested | (19,306) |
Number of shares, Ending Balance | 231,149 |
Weighted Average Award Date Fair Value, Beginning Balance | $ / shares | $ 5.18 |
Weighted Average Award Date Fair Value, Granted | $ / shares | 1.46 |
Weighted Average Award Date Fair Value, Forfeited | $ / shares | 2.58 |
Weighted Average Award Date Fair Value, Vested | $ / shares | 7.79 |
Weighted Average Award Date Fair Value, Ending Balance | $ / shares | $ 4.04 |
Restricted Stock Award RSA [Member] | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Number of shares, Beginning Balance | 52,778 |
Number of shares, Vested | (15,139) |
Number of shares, Ending Balance | 37,639 |
Weighted Average Award Date Fair Value, Beginning Balance | $ / shares | $ 16.09 |
Weighted Average Award Date Fair Value, Vested | $ / shares | 18.19 |
Weighted Average Award Date Fair Value, Ending Balance | $ / shares | $ 15.24 |
Director Stock Awards [Member] | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Number of shares, Beginning Balance | 5,000 |
Number of shares, Granted | 52,500 |
Number of shares, Vested | (26,250) |
Number of shares, Ending Balance | 31,250 |
Weighted Average Award Date Fair Value, Beginning Balance | $ / shares | $ 12.45 |
Weighted Average Award Date Fair Value, Granted | $ / shares | 1.25 |
Weighted Average Award Date Fair Value, Ending Balance | $ / shares | $ 3.04 |
Related Party Transactions - Ad
Related Party Transactions - Additional Information (Details) - USD ($) | 3 Months Ended | 6 Months Ended | |||||
Apr. 19, 2023 | May 26, 2021 | Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | Dec. 31, 2023 | |
Related Party Transaction [Line Items] | |||||||
Interest expense recognized | $ 187,265 | $ 183,593 | $ 377,162 | $ 367,185 | |||
Related Party Manufacturer [Member] | |||||||
Related Party Transaction [Line Items] | |||||||
Purchase goods from related party | 0 | $ 0 | |||||
Other liabilities | 807 | 807 | $ 807 | ||||
Buyer [Member] | |||||||
Related Party Transaction [Line Items] | |||||||
Transaction date | May 26, 2021 | ||||||
Total purchase price | $ 7,500,000 | ||||||
Class A Common Stock [Member] | |||||||
Related Party Transaction [Line Items] | |||||||
Warrant, exercise price per share | $ 0.5134 | ||||||
Aggregate warrants | 7,964,550 | ||||||
Number of warrants exercised for shares of common stock | 530,970 | ||||||
Promissory Notes [Member] | |||||||
Related Party Transaction [Line Items] | |||||||
Debt instrument, issuance date | Apr. 19, 2023 | ||||||
Debt instrument, interest rate | 12% | ||||||
Debt instrument, maturity date | Dec. 31, 2024 | ||||||
Promissory Notes [Member] | Minimum [Member] | |||||||
Related Party Transaction [Line Items] | |||||||
Gross proceeds from issuance of notes | $ 3,000,000 | ||||||
Promissory Notes [Member] | Class A Common Stock [Member] | |||||||
Related Party Transaction [Line Items] | |||||||
Warrant, exercise price per share | $ 0.1833 | ||||||
Warrant offering term | 3 years 3 months | ||||||
Unsecured Convertible Promissory Notes [Member] | |||||||
Related Party Transaction [Line Items] | |||||||
Debt instrument, principal amount | $ 2,954,545 | $ 2,954,545 | |||||
Debt instrument, interest rate | 12% | 12% | |||||
Debt instrument, maturity date | Dec. 31, 2024 | ||||||
Debt instrument, discount rate | 1% | ||||||
Unsecured Convertible Promissory Notes [Member] | Minimum [Member] | |||||||
Related Party Transaction [Line Items] | |||||||
Gross proceeds from issuance of notes | $ 3,000,000 | ||||||
Lease Agreement [Member] | |||||||
Related Party Transaction [Line Items] | |||||||
Lease terms | In connection with the consummation of the Sale and Leaseback Transaction, the Company entered into a lease agreement (the “Lease Agreement”) with Buyer pursuant to which the Company leased back the Real Property from Buyer for an initial term of twelve (12) years unless earlier terminated or extended in accordance with the terms of the Lease Agreement. Under the Lease Agreement, the Company’s financial obligations include base rent of approximately $60,000 per month, which rent will increase on an annual basis at two percent (2%) over the initial term and two-and-a-half percent (2.5%) during any extension term. The Company is also responsible for all monthly expenses related to the leased facility, including insurance premiums, taxes and other expenses, such as utilities. Under the Lease Agreement, the Company has three (3) options to extend the term of the lease by five (5) years for each such option and a one-time right and option to purchase the Real Property at a price that escalates over time and, if Buyer decides to sell the Real Property, the Company has a right of first refusal to purchase the Real Property on the same terms offered to any third party. | ||||||
Initial term | 12 years | ||||||
Base rent | $ 60,000 | ||||||
Percentage of increase in base rent | 2% | ||||||
Percentage of increase in base rent over initial term | 2.50% | ||||||
Options to extend term | Under the Lease Agreement, the Company has three (3) options to extend the term of the lease by five (5) years for each such option | ||||||
Extended term | 5 years | ||||||
Certain Members of Management and Board of Directors [Member] | |||||||
Related Party Transaction [Line Items] | |||||||
Debt instrument, principal amount | 4,089,000 | $ 4,089,000 | 4,089,000 | ||||
Aggregate warrants | 2,288,664 | ||||||
Certain Members of Management and Board of Directors [Member] | Class A Common Stock [Member] | |||||||
Related Party Transaction [Line Items] | |||||||
Debt instrument, principal amount | $ 1,175,000 | $ 1,175,000 | 1,175,000 | ||||
Number of warrants exercised for shares of common stock | 152,577 | 152,577 | |||||
Certain Members of Management and Board of Directors [Member] | Promissory Notes [Member] | |||||||
Related Party Transaction [Line Items] | |||||||
Debt instrument, principal amount | $ 1,175,000 | ||||||
Aggregate warrants | 2,288,664 | ||||||
Certain Members of Management and Board of Directors [Member] | Promissory Notes [Member] | Class A Common Stock [Member] | |||||||
Related Party Transaction [Line Items] | |||||||
Warrant, exercise price per share | $ 2.75 | ||||||
Number of warrants exercised for shares of common stock | 152,577 | ||||||
Executive Officer [Member] | |||||||
Related Party Transaction [Line Items] | |||||||
Other liabilities | $ 72,000 | $ 72,000 | 100,000 | ||||
Executive officer fee | $ 100,000 | ||||||
Annual fee percentage | 7.20% | ||||||
Related Party [Member] | |||||||
Related Party Transaction [Line Items] | |||||||
Other liabilities | 282,830 | $ 282,830 | $ 278,771 | ||||
Related Party [Member] | Unsecured Convertible Promissory Notes [Member] | |||||||
Related Party Transaction [Line Items] | |||||||
Debt instrument, principal amount | $ 1,702,020 | $ 1,702,020 | |||||
Debt instrument, interest rate | 12% | 12% | |||||
Debt instrument, discount rate | 1% | ||||||
Related Party [Member] | Unsecured Convertible Promissory Notes [Member] | Minimum [Member] | |||||||
Related Party Transaction [Line Items] | |||||||
Gross proceeds from issuance of notes | $ 3,000,000 |
Subsequent Events - Additional
Subsequent Events - Additional Information (Details) - Unsecured Convertible Promissory Notes [Member] - USD ($) | 1 Months Ended | 3 Months Ended |
Jul. 31, 2024 | Jun. 30, 2024 | |
Subsequent Event [Line Items] | ||
Debt instrument, principal amount | $ 2,954,545 | |
Debt instrument, interest rate | 12% | |
Debt instrument, discount rate | 1% | |
Debt instrument, maturity date | Dec. 31, 2024 | |
Minimum [Member] | ||
Subsequent Event [Line Items] | ||
Gross proceeds from issuance of notes | $ 3,000,000 | |
Subsequent Event [Member] | ||
Subsequent Event [Line Items] | ||
Debt instrument, principal amount | $ 353,535 | |
Debt instrument, interest rate | 12% | |
Debt instrument, discount rate | 1% | |
Debt instrument, maturity date | Dec. 31, 2024 | |
Subsequent Event [Member] | Minimum [Member] | ||
Subsequent Event [Line Items] | ||
Gross proceeds from issuance of notes | $ 3,000,000 | |
Subsequent Event [Member] | Fund Growth in Working Capital and General Operations [Member] | ||
Subsequent Event [Line Items] | ||
Gross proceeds from issuance of notes | $ 350,000 |